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 The vascular system plays a diverse role in the human body. It acts as a conduit, 
transferring material, energy and information (functions of “conduction”). It is capable 
of mechanical adaptation, plays a role in the formation, conduction and dissipation of 
hemodynamic waves. It has receptor functions neurotransmitters are released in them 
and are important components of synthesis of different tissues. It plays a role in the 
biochemical conversion of substances in blood plasma in hemostasis and transmural 
transport of different substances.  
 Hypertension is a well-recognized risk factor for cardiovascular and renal 
diseases and may lead to increased risk of stroke (Bergan (Bergan, Pascarella, & 
Schmid-Schönbein, 2008). A study of men and women aged 45 to 83 years showed the 
age-standardized prevalence of hypertension at baseline was 74.3% for men and 70.2% 
for women (Lacruz  ., 2015) . Small resistance arteries play a key role in the control of 
blood pressure. These segments are responsible for the most significant decrease of 
hydrostatic pressure along the circulatory system. The rise in blood pressure affects the 
structure and morphology of the vessel wall (Hayashi & Naiki, 2009). Angiotensin II is 
greatly implicated in vascular remodeling of small-resistance arteries (Intengan & 
Schiffrin, 2000; Neves et al., 2004; Neves, Virdis, & Schiffrin, 2003). Sex differences 
in hypertension have been described, and are at least in part thought to be due to the 
effects of estradiol and testosterone (Barton, Prossnitz, & Meyer, 2012), but little is 
known about the mechanisms through which sex hormones affect the remodeling of 
coronary resistance arteries. 
 A cross-sectional study of 2,211 men and women revealed that varicose veins 
affect 28% of the adult female population compared with in 15% of the adult males 
(Raffetto et al., 2010).The primary cause of the development of lower limb varicosity 
has not been established, but pressure loading, vein valve dysfunction, diabetes, obesity, 
smoking and age, pregnancy, standing for long periods of time have been implicated as 
major contributing factors to this to the progression of this disease. (Raffetto & Khalil, 
2008; Raffetto et al., 2010). The pathomechanisms underlying the development of 
varicose vein is still inconclusive, and little is known about the effects of flow 




Histology and physiology of the vessel wall 
 




Histology of veins and arteries. 
 (Figure from - (Torres-Vázquez, Kamei, & Weinstein, 2003)) Veins and arteries and 
veins are both composed of similar tissue layers,  an inner endothelium (tunica intima) 
surrounded by internal elastic tissue, a layer of smooth muscle cells (tunica media), 
external elastic tissue, and fibrous connective tissue (tunica adventitia).  
 
 Arteries and veins have are composed of the same three layers, the tunica intima, 
the tunica media and the tunica adventitia.   The tunica intima lines the lumen of the 
blood vessels. It consists of simple squamous epithelium and a thin basal membrane. 
The simple squamous epithelium provides a smooth surface for unperturbed blood flow. 
The tunica intima is collectively referred to as the endothelium. The tunica media is 
made of smooth muscle and elastic fibers. It is responsible for vasodialation and 
vasoconstriction of the blood vessels. The tunica adventitia is the most superficial layer.  
It is made of collagen fibers running in all directions for strength in many different 
directions.  In arterioles the tunica intima consists of a single layer of squamous 
epithelium, the tunica media a few or single layer of smooth muscle cells and the tunica 




 Arteries and veins are exposed to different pressures of blood flow.  These 
differences are reflected in the structure of the vessels.  Arteries experience a pressure 
wave as blood is pumped from the heart therefore the walls of arteries are much thicker 
than those of veins.  In addition, the muscular tunica media is much thicker in arteries 
than in veins.  As a result, arteries have a more uniform, circular shape. Veins are not 
exposed to pressure waves, therefore the vessel walls of veins are thinner than arteries 
and do not have as much tunica media.  The tunica media is smaller in relation to the 
lumen than in arteries.  Veins are more irregular in shape.(Hall, 2015; Torres-Vázquez 
et al., 2003) 
 Vascular endothelial cells in the resistant arteries are constantly exposed to the 
dynamic changes of blood flow (Fig. 2). The hemodynamic forces can be resolved into 
three components: (1) shear stress, the tangential frictional force acting at the 
endothelial cell surface, (2) hydrostatic pressure, the perpendicular force acting on the 





Figure from (Hsiai & Wu, 2008) 
Hemodynamic forces acting on blood vessels 
Diagram of hemodynamic forces acting on endothelial cells and smooth muscle cells in 
the blood vessel wall. (a) Fluid shear stress which is the tangential frictional force by 
virtue of blood viscosity, acts on endothelial cells mainly. (b) Cyclic strain exerts a 
circumferential stretch on arterial wall in response to cardiac contraction. Hydrostatic 




exposed to both biomechanical and biochemical stimuli, which modulate endothelial 
functional phenotype. The biochemical stimuli include hormones, growth factors, 
cytokines that may be delivered via the blood or via autocrine or paracrine mechanisms 
(Hsiai & Wu, 2008). 
  
 
II./1. Hemodynamic control of vessel wall biomechanics 
 
 It has long been established that the conduction and wave 
forming/conducting/dissipating functions are determined by the geometrical and elastic 
properties of vessels. These characteristics, however may adapt to a set of physiological 
and pathological factors (Monos, 1986). 
 
Short term adaptation 
 While alterations in tissue composition are usually seen in long term adaptation, 
short term adaptation or regulation of the vessel wall is most commonly achieved 
through setting of the myogenic tone of the vessel. Changes in geometrical and elastic 
properties are key elements in this process (Monos, 1986). The diameter of the vessel is 
determined by transmural pressure as well as by the elastic and contractile elements of 
the wall. Vessel tone (which may be measured by comparing vessel diameters in an 
active and passive state) is set by several factors.  
 The intrinsic tone, which can be observed on isolated vessel segments is 
modulated by the endothelium and by metabolic, endorine, neural and hemodynamic 
factors. All these factors therefore play a role in the control of peripheral resistance 
(Hall, 2015; Mulvany & Aalkjaer, 1990). 
Myogenic tone is considered to be a key factor in the local regulation of blood flow 
(Bayliss, 1902)(Figure 3.). Myogenic response is defined as active vessel contraction to 
an  increase of intravascular pressure (Bayliss, 1902; Kuo, Chilian, & Davis, 1991; Kuo, 
Davis, & Chilian, 1991; Meininger & Davis, 1992; Rajagopalan, Dube, & Canty, 1995) 
Mulvany and  Aaljaker (Mulvany & Aalkjaer, 1990) described that this myogenic 
response is regulated by stretch or pressure response, mostly in small arteries and 






levels, due mechanically sensitive Ca
2+
 membrane channels have been described to be 




Myogenic tone - active vessel contraction to an  increase of intravascular pressure 
 
 Myogenic response may be studied in cannulated and pressurized vessel 
segment preparations in vitro. This way other variables can be controlled 
(neurohumoral, metabolic factors etc.) (Kuo, Davis, & Chilian, 1988; Meininger & 
Davis, 1992). Resistance artery control of local tissue flow, partially due to the 
myogenic tone is very effective according to the Hagen-Poiseuille law. In a thin, rigid 
tube, if flow is laminar the intensity of flow (Q) is directly proportional to the pressure 
difference between the points of the tube (P1-P2) and also proportional to the fourth 
power of the inner radius (r). In analogy with the Ohm’s law used in electrodynamics, 
we can compute hydrodynamic resistance, and applying the Hagen-Poiseuille law, R= 
(P1-P2)/Q=8xLη/πr
4
. Thus vascular resistance is directly proportional to the length of 
the vessel and the viscosity of blood, and is inversely proportional to the fourth power 
of the radius of the vessel. In consequence, a key factor in the acute regulation of blood 
flow is vessel diameter (Fonyó, 2011; Hall, 2015). As the intensity of flow changes in 
correspondence with the fourth power of the radius of the vessel wall, minor alterations 
in diameter lead to significant changes in flow. Every factor that influences the smooth 
muscle tone and reactivity of vessels may have short-term regulatory effects on 
hemodynamic adaptation (Monos, 1986). Flow autoregulation is implemented at the 




In addition to pressure and wall stretch, flow, which, in the arteries is pulsatile 
flow, also induces both long and short term reactions within the vessel wall. Release of 
vasoactive agents and immediate alterations in vessel diameter will be resulted 
(Cronenwett & Johnston, 2014). In case the endothelium is damaged there is a direct 
action of blood flow shear stress on the smooth muscel cells and fibroblast on the vessel 
wall. This may come from secretion, laminar, pulsatile, and oscillating flow shear 
stresses. These stresses may lead to alterations in alignment, contraction, proliferation, 
apoptosis, differentiation, and migration in the remaining cells of the vascular wall. 
Smooth muscle cells, and fibroblast both posses a high degree of plasticity that allows 
large scale yet reversible changes within the cell in response to alterations in local 
environmental factors. This is why smooth muscle cells, and fibroblasts may play a 
crucial role in vascular repair and remodeling (Shi & Tarbell, 2011). In a physiological 
state they are arranged in distinct patterns within the vessel wall. There is evidence that 
different types of mechanical stimuli regulate vascular cell morphology. Fluid shear 
may lead to the orientation of the endothelial cells parallel with flow (Chiu, Usami, & 
Chien, 2009). Laminar shear stress may induce perpendicular alignment of the smooth 
muscle cells. The alignment of smooth muscle cells semmed to dependend on and 
cytoskeleton-based mechanisms (Lee, Graham, Dela Cruz, Ratcliffe, & Karlon, 2002). 
Pulsatile strain and shear stress resulted in a circumferential pattern alignment of the 
smooth muscle cells. It has been found that non-uniform blood flow causes the smooth 
muscle cells to align perpendicular to luminal flow (parallel to transmural flow) and 
migrate toward the lumen, while uniform shear stress does not significantly affect 
smooth muscle cell orientation and migration. Circumferential alignment of the smooth 
muscle cells alloes the blood vessels to better resist tangential stresses induced by blood 
pressure (Shi & Tarbell, 2011). 
  
Long-term adaptation 
 It has long been established that the alterations in tissue composition due to 
changes in hemodynamic forces may be part of physiological adaptation mechanisms, 
but also can be pathological processes (Monos, 1986). It is also known that the vascular 
wall is composed of elastic and of non-elastic components, and all these determine its 




appears instantaneously in purely elastic body. The materials, where there is time gap 
before the strain appears are defined as viscoelastic (Milnor, 1972). The main building 
components of the vessel wall are elastin, collagen and smooth muscle cells. Wall 
composition will play a central role in determining the elastic response of the vessel in 
response to intraluminal pressure changes. 
 Elastin (Figure 4.) is a highly elastic biological material, a protein that allows 
many tissues to resume their shape after stretching or contracting. For elastin, an almost 
linear stress-strain relationship is characteristic. Collagens (Figure 4.) are astructural 
proteins found in a variety of tissue in abundance. The vital importance of collagen as a 
scaffold demands a manifold of essential characteristics, including thermal stability, 
mechanical strength, and the ability to engage in specific interactions with other 
biomolecules. The collagen molecule consists of helically wound chains of amino-acids. 
These helices are woven (Shoulders & Raines, 2009) into microfibrils, which weave 
together into subfibrils and fibrils. Due to this structural characteristic, this “waviness” 
the stress—strain relationship shows a very low stiffness at small stretch ratios. The 
stiffness increases fast once the fibers are deformed into straight lines. 
 
a,       b, 
Figure 4.  
Main contractile and force-bearing structural proteins of the vascular wall 




 Any transmural pressure within vessel exerts a force on the vessel wall that 
would tend to rip the wall apart were it not for the opposing forces supplied by the 
muscle and connective tissue of the vessel wall. This force is equal to the product of the 




tangential wall tension.  The relationship is defined by the Law of Laplace. The Law of 
Laplace applies directly only to cylinders with thin walls. Blood vessel walls are 
sufficiently thick, so in vascular mechanics the tangential wall stress is preferably used 
(Rhoades & Bell, 2012). Tangential wall stress of the vessel (σ) is determined by 
transmural pressure (P), vessel inner radius (ri) and wall thickness (h). σ=Pri/h (Laplace-
Frank equation).  Changes in wall thickness therefore lead to alterations in wall stress. 
Blood vessels that have thick walls relative to their radius are able to withstand higher 
pressure than vessels with small ratios because in the former wall stress is lower. Not 
pressure, but but wall stress is what must be overcome to contract a blood vessel 
(Rhoades & Bell, 2012). 
 Blood vessels are constantly exposed to mechanical forces in the form of cyclic 
strain and shear stress. The main source of cyclic strain is blood pressure as radial and 
tangential forces in the vessel wall work to counteract the intraluminal pressure. 
Hemodynamic forces have long been recognized as key modulators of protein synthesis, 
cell morphology migration, differentiation and proliferation. The Laplace-Frank 
equation describes the tension per unit of thickness of the wall, which represents the 
stress exerted on the wall in the circumferential direction. Circumferential stress affects 
all cell types in the vessel wall, whereas shear stress principally acts on the 
endothelium. Pulsatile flow also plays a role in the long term adaptation of the vessel 
wall. Chronic changes in mechanical forces lead to vascular remodeling and adaptive 
alterations in vessel shape and composition over time (Cronenwett & Johnston, 2014) 
 Vascular remodeling may occur as a result of changes in pressure, radius or 
blood flow. Smooth muscle cell hypertrophy and elevation in collagen and elastin 
production have been shown to accompany increased circumferential stress (Prado & 
Rossi, 2006). The opposite has been demonstrated as well, that a decrease in 
circumferential wall stress leads to wall atrophy (Cronenwett & Johnston, 2014). 
Studies have shown that when the diameter of a vessel increases, the number of lamellar 
units and the overall thickness of the vessel wall increase also in order to maintain 
circumferential wall stress. In elastic arteries the adaptive response physiologically 
works to normalize tensile stress. 
 In a tube with rigid, inflexible walls the volume of fluid is the same independent 




vessels are viscoelastic. Consequently, the volume contained within them is a function 
of both the pressure difference across their wall (transmural pressure - defined as the 
difference of pressure inside versus outside the vessel wall) and the degree of 
flexibility/elasticity of the vessel wall itself (Rhoades & Bell, 2012). Studies have 
revealed that average circumferential (tangential) wall stress increases with increased 
pressure and vessel size (Bérczi, Tóth, Kovách, & Monos, 1990; Monos, 1986; Monos 
& Kovách, 1980; Szekeres et al., 1998). 
 Young's modulus, also known as the elastic modulus, is a measure of the 
stiffness of a solid material. Constant elastic modulus (independent of strain) 
characterizes the linear elastic solid materials. This modulus defines the relationship 
between stress (force per unit area) and strain (proportional deformation) in a material 
(Bergel, 1961). The vessel wall is not a linear elastic solid material: the stress/strain 
ratio increases with increasing strain. Elastic modulus thus can be defined for a short 
range of the stress/strain relationship for given values of stress (in case of vessels, 
intraluminal pressure) only. Such moduli are called incremental elastic moduli and are 
plotted against stress or pressure (Monos 1986).  Vascular stiffness is often expressed 
by the circumferential incremental elastic modulus, computed from the equation Einc= 






), where Einc is the incremental elastic modulus, ri is the inner 
radius, ro is the outer radius, and Δ ro is the change in the outer radius in response to an 
intraluminal pressure change of P. When the parameters defined at specific pressure 
levels, different values may be expected at different pressure levels because pressure-
diameter relationships of vessels are nonlinear (Hayashi & Naiki, 2009). 
 One problem with compliance is that different-sized vessels can not be 
compared. For example, a large stiff -walled vessel may have a higher compliance value 
than a tiny flexible vessel. For this reason, the percentage increase in volume for a given 
increase in pressure may be used as a means of comparing distensibility between vessels 
and segments of the vasculature of different sizes. This value is called vascular 
distensibility D= ΔV/ Vo ΔP (Rhoades & Bell, 2012). 
 The composition of the vessel wall determines its elasticity. From the elastic 
parameters used distensibility will depend both on vessel geometry and wall elasticity, 
while elastic modulus, especially it is expressed as a function of wall stress will be an 




II./2. Humoral control of the biomechanical properties of the vessel wall  
 There are a myriad of agents that have an effect on the vascular system. These 
may be direct physical forces, chemical agents, hormones, paracrine substances, and 
receptor-mediated hormonal and neurotransmitter agonists. These agents may have an 
effect on the endothelium or on the vascular smooth muscle. The 





):  During vascular smooth muscle contraction actin and myosin 
filaments slide over one another. Compared with skeletal muscle, smooth muscle 
contracts very slowly, develops and maintains high forces for long periods of time. Also 
it uses a relatively low amount of adenosine triphosphate (ATP) in the process. This 
contraction is controlled by intracellular free calcium ion concentration. The calcium 
may enter the smooth muscle cells via voltage-gated calcium channels, receptor-
dependent and mechanosensitive calcium channels, and by release from the 
sarcoplasmic reticulum. It is released from the endoplasmic reticulum by certain agents, 
IP3 being the most important secon messenger with such an effect.  Calcium binds to 
calmodulin, which in turn activates myosin light chain kinase to initiate crossbridge 
attachments (Fonyó, 2011; Hall, 2015). 
 Potassium (K
+
): Potassium causes membrane depolarization, this in turn results 
in the activation of calcium channels.  
 Sodium (Na
+
): Decreased transmembrane sodium gradient leads to decreased 
activation of plasma membrane sodium/calcium exchange and increased intracellular 




pump is responsible for the base membrane potential in 
cells. The inward movement of sodium ions and the outward movement of potassium 
ions are passive and the reverse movements against the electrochemical gradients 




pump. Maintenance of a normal electrical 









regulated by several factors including the intracellular sodium concentration and the 




ATP-ase alters the 
membrane potential and influences vessel function in an essential way.(Hall, 2015; 




 Increased transmural pressure: Increased transmural pressure leads to the 
activation of stretch-dependent calcium channels. Alteration of vessel wall tension may 
lead to a myogenic response that does not require the presence of the endothelium. It is 
accompanied by a membrane depolarization and an increase of the intracellular Ca2+ 
concentration, which depends largely on an influx of extracellular calcium via voltage-




 Norepinephrine (NA): Norepinephrine binds to either alpha or beta adrenergic 
receptors. Alpha receptors are divided into subtypes α1 and α2; beta receptors into 
subtypes β1, β2, and β3. All of these function as G protein-coupled receptors, meaning 
that they exert their effects via a complex second messenger system. 
Norepinephrine is a powerful vasoconstrictor. When the sympathetic nervous 
system is activated (through stress or exercise) the sympathetic nerve endings release 
norepinephrine into the tissues. This surge of norepinephrine has a stimulative effect on 
the heart, contracts the veins and arterioles. Through a dual control system 
norepinephrine may have an effect on tissues not only through direct simulation of the 
nerves, but through the indirect effects of circulating norepinephrine. (Hall, 2015) 
Norepinephrine binds to α-adrenoceptors on the cell membrane, which is linked to a 
membrane-bound regulatory protein, heterotrimeric G-protein (guanine nucleotide 
binding protein) with q/11 type alfa subunits. This activates phospholipase C, leading to 
hydrolysis of membrane-bound phosphatidyl inositol bisphosphate to yield inositol 
triphosphate and diacylglycerol. Inositol bisphosphate then causes the release of 
calcium from the sarcoplasmic reticulum, which ultimately leads to smooth muscle 
contraction reduction in vessel radius and thus increase in vascular resistance. 
Norepinephrine plays an important role in the regulation of myocardial perfusion, as has 
an effect on the vascular tone of coronaries (Quillen, Sellke, Banitt, & Harrison, 1992). 
There are both α and β receptors present on coronaries. α receptors cause 
vasoconstriction and β receptors vasodilation.  The α1 receptors and α2 receptors found 
on coronary vascular smooth muscle cells cause vasoconstriction through smooth 
muscle contraction. There are α2 receptors on endothelial cells, these cause vasodilation 




Vanhoutte, 1989). There are β2 receptors on coronary resistance arteries, here 
norepinephrine causes vasodilation through increasing cyclic adenosine monophosphate 
(cAMP) levels in vascular smooth muscle cells (Bassenge & Heusch, 1990; Hall, 2015) 
 Acetylcholine (Ach): Acetylcholine is a parasympathetic neurotransmitter. It 
activates a range of muscarinic M receptors. In endothelial cells it may activate M1, 
M2, or M3 receptors, which opens plasma membrane calcium channels, activates 
phospholipase C and increases the production of IP3 and Diacylglycerol (DAG). Most 
of the effect of acetylcholine in vessels is endothelium dependent. If the endothelium is 
damaged, acetylcholine induced vasodilation (see next section) turns into 
vasoconstriction in isolated aorta preparations.(Nasa, Kume, & Takeo, 1997; 
Tangsucharit et al., 2016) 
 Serotonin may cause vasoconstriction through the activation of 5-
hydroxytryptamine (5-HT2) receptors which open receptor-operated plasma membrane 
calcium channels. The constrictor action of the serotonine may be due to a direct 
activation of vascular smooth muscle, augmentation of the action of other endogenous 
vasoconstrictors such as catecholamines, angiotensin II and the release of 
norepinephrine from adrenergic nerves. (Ayme-Dietrich, Aubertin-Kirch, Maroteaux, & 
Monassier, 2017) 
  Vasopressin: Vasopressin is a powerful vasoconstrictor in the body when 
applied in higher concentrations. It is formed in nerve cells in the hypothalamus, is 
transported to the posterior pituitary gland, and from here it is secreted into the blood. It 
is a key factor in fluid volume control under physiological conditions. Direct vascular 
control is a less important function of vasopressin in physiological concentrations.  
 Angiotensin II (AngII): Angiotensin II is one of the most powerful 
vasoconstrictor substance known. It causes significant constriction of the small arteries 
and arterioles. It thereby plays an important role in determining total peripheral 
resistance, and increases arterial pressure. It activates angiotensin II receptors, and 
induces G protein-dependent signaling pathways (IP3 /DAG pathways). IP3 binds to its 
receptor on sarcoplasmic reticulum, opening a channel that allows calcium influx into 
the cytoplasm. Ca
2+
 then binds to calmodulin and activates the myosin light chain 




interaction between actin and myosin, causing smooth muscle cell contraction (Mehta & 
Griendling, 2007). 
  Endothelin: Endothelin is yet another potent vasoconstrictor.  It may be found in 
the endothelium of the vasculature.  The most typical stimulus for release is damage to 
the endothelium. Subtypes of endothelin receptors have been identifies, certain subtypes 
mediate vasoconstriction while other receptors mediate both vasoconstriction and 
vasodilatation. ETA is a subtype for vasoconstriction found in the smooth muscle cells. 
It activates receptors, which stimulate of phospholipase C, formation of IP3, and release 
of calcium from the sarcoplasmic reticulum.(La & Reid, 1995) 
 Thromboxane A2 (TxA2) is an extremely potent vasoconstrictor (Yamada et al., 
2003) derived from the metabolism of arachidonic acid. (Scornik & Toro, 1992) 
Thromboxane (TxA2) is a vasoactive agent. It is produced in response to a myriad of 
stimuli, from the cell membrane. There are different types of receptors that mediate the 
effects of thromboxane along with prostaglandin on coronary vascular smooth muscle. 
The high-affinity (kD: > or = 1 nM) Prostaglandin H2 PGH2/TxA2 receptors mediate 
the contractile actions of TxA2. Through different G-proteins these receptors activate 
intracellular signal transduction pathways which control intracellular calcium level 
Adenosine triphosphate (ATP)-dependent K-channels are regulated by TxA2  and may 
be involved in the determination of coronary smooth muscle tone. (Schrör, 1993). TxA2 




 Nitric oxide (NO): Agents that control tissue blood flow locally typically only 
dilate only the small resistance arteries as they can only reach these, and not the larger 
caliber vessels upstream. Even so, when blood flow increases in the microvascular area, 
it leads to secondary mechanisms that have a vasodilatative effect on larger arteries. The 
endothelium in the small resistance arteries synthesizes substances that induce 
vasodilation. The key vasodilator substance is endothelium derived relaxing factor 
(EDRF). This mainly consists of nitric oxide. This has a very short half-life in the blood 
stream - only 6 seconds (Cocks, Angus, Campbell, & Campbell, 1985). Rapid flow of 




mechanical stretch leads to a significant increase in the release of nitric oxide, which 
leads to vasodilation of the vessels. This is fortunate because this mechanism causes 
vasodilation in the upstream arterial blood vessels whenever microvascular blood flow 
increases downstream. Without this mechanism the effectiveness of local blood flow 
control would be significantly decreased as a significant part of the resistance to blood 
flow is in the upstream small arteries. NO stimulates guanylate cyclase of the vascular 
smooth muscle, formation of cGMP, calcium removal and hyperpolarization. It also 
inhibits voltage-gated calcium channels.(Johns, 1991) 
 Hyperkalemia: Vascular smooth muscle membrane is depolarized in highly 
hyperkalemic solution and a contraction will be the result. However, in in vivo 
conditions, local hyperkalemia will mostly result vasodilation. 
 Magnesium: An increase in magnesium ion concentration causes powerful 
vasodilation because magnesium ions inhibit smooth muscle contraction. This is 
thought to be a direct action of magnesium, independent of NO.(Teragawa, Kato, 
Yamagata, Matsuura, & Kajiyama, 2001) 
 
Vasodilators: Receptor-mediated 
 Epinephrine: Epinephrine leads to vasodilation through β2 receptor-mediated 
activation of adenyl cyclase resulting in the formation of cAMP (cyclic adenosine 
monophosphate). 
 Adenosine: Adenosine is produced within the myocardial cell. It plays a key role 
in the local metabolic regulation of coronary circulation. Adenosine acts on purinergic 
receptors. A1 receptor subtypes are found in the myocardium, and A2 receptor subtypes 
are found in the vasculature. Adenosine acts through receptor activation of ATP-
dependent potassium channels. This leads to membrane hyperpolarization and closure 
of voltage-gated calcium channels. The vascular A2 receptors found on vascular smooth 
muscle cells stimulate the formation of cAMP. This leads to vasodilation in the 
coronaries.  It also leads to hyperpolarization resulting from opening of potassium 
channels. Adenosine is also an endothelium-independent vasodilator (Kuo, Davis, & 
Chilian, 1995) 
 Histamine (H): Histamine acts on the H2 receptor as avasodilator. H2 receptors 




cells. Vasodilator effect is mediated through cyclic Adenosine monophosphate (cAMP); 
H1 receptors may be found on endothelial cells, and their stimulation leads to the 
formation of NO (Ebeigbe & Talabi, 2014).   
 Bradykinin (BK): The group of agents called kinins are potent vasodilators. 
They are small polypeptides that are split away by proteolytic enzymes from alpha2-
globulins in the plasma or tissue fluids. One of the key enzymes is kallikrein. It is 
present in the bloodstream and the tissue fluids in its inactive form, and may be 
activated by a myriad of factors, such as inflammation, chemical or physical effects. 
When it is activated, kallikrein acts on alpha microglobulin to release a kinin called 
kallidin. Kallidin is then converted into bradykinin by tissue enzymes. Bradykinin has a 
short life, only a few minutes, as it is inactivated by carboxypeptidase or by the 
converting enzyme, which activates angiotensin. Kallikrein enzyme is deactivated by 
the the kallikrein inhibitor. Bradykinin causes vasodilation and increased capillary 
permeability (Hall, 2015). BK has been shown to play a role in the physiological 
regulation of coronary microcirculation.  BK is produced in both the myocardium and in 
the vascular tissue. BK may act on different receptors. Receptors may be found either 
on the endothelium or on vascular smooth muscle cells. Bradykinin causes 
endothelium-dependent vasodilation on constitutive B2 receptors located on endothelial 
cells of the vascular wall (Okamura & Toda, 1989), and vasoconstriction on smooth 
muscle cells, which is mediated by B1 receptors. The effects of bradykinin are thereby 
usually a combination of an endothelium–dependent vasodilator and a direct smooth 
muscle- dependent vasoconstrictor effect. The endothelium-dependent action of 
bradykinin through the activation of nitric - oxide synthase (Kuo, Chilian, & Davis, 
1991). There is also evidence, that bradykinin has an NO-idependent vasodilation effect 
which may be mediated by prostacyclin and endothelium-derived hyperpolarizing factor 
(EDHF) (Okamura & Toda, 1989). There is a body of evidence to support that 
bradykinin is a potent vasodilator on coronary arteries of different species and humans 
both on isolated vessels and heart preparations, such as in situ  (Dézsi, Szekeres, & 
Schiszler, 1995; Rajagopalan et al., 1995). Bradykinin induced vasodilation appears to 







Comparison of metabolic control mechanisms in coronaries and veins  
 
Metabolic control mechanisms in coronary blood flow. 
  Myocardial metabolic demand is matched by an increase in coronary blood flow 
under physiological conditions. This process appears to be largely regulated by local 




Control mechanisms of coronary blood flow. Humoral agnets play a paramount role in 
the regulation of coronary blood flow. 
(Figure- http://www.sci.utah.edu/~macleod/bioen/be6000/notes/L12-control-circ.pdf) 
 
  Adenosine – considerations in the coronary arteries. Adenosine is a substance 
that plays a cardinal role in the regulation of coronary blood flow adaptations during 
rapid changes in cardiac performance (Bassenge & Heusch, 1990). Adenosine is 
produced within the myocardial cell, when myocardial metabolism increases. It diffuses 
to the vessels, leading to vasodilation (Bassenge & Heusch, 1990). There is evidence to 
suggest, that small coronary arteries are the primary target for the effects of adenosine 
(Bassenge & Heusch, 1990; Kuo et al., 1995; Muller et al., 1996). When the 
myocardium becomes “underperfused” due to a rise in metabolic demand, hypoxia, 
hypercapnia, and acidosis also contribute to vasodilation. Metabolism becomes 
anaerobic, lactic acid is released and acidosis develops (Hall, 2015). Other agents, such 
as prostaglandins and bradykinin may also be released, and may contribute to the 




important regulatory mechanism in the humoral control of microvascular resistance 
(Muller et al., 1996).  Neural stimuli may have both direct and indirect effects on 
coronary microcirculation. Norepinephrine from the sympathetic nerves act directly 
through the release of neurotransmitters on the coronaries. Indirect effects are caused by 
decreased or increased activity of the heart (Hall, 2015). Therefore sympathetic 
neurotransmitters can elicit either vasoconstrictor or vasodilator effect, depending on 
the presence of receptors.  In the coronaries we find both α and β receptors with the 
predominance of β receptors (Juhász-Nagy & Szentiványi, 1973). There are also α2 
receptors in the endothelium, which are responsible for the release of NO and therefore 
have vasodilatative effects. 
  
Endothelium dependent control mechanisms 
  The endothelium is the active participant of more than one regulatory 
mechanism (Fiugre 6.). One of the most important vasodilator agents is produced by 
and released from the endothelium. It is the endothelium derived relaxing factor 
(EDRF) which is composed principally of nitric oxide. Blood flow in the vessels causes 
shear stress, leading to contortion of the endothelial cells leading to an increased release 
of nitric oxide. (Bassenge & Heusch, 1990; Furchgott & Vanhoutte, 1989; Kuo et al., 





Figure from (Wang, 2009) 




NO is produced from the endothelium by NO synthase (NOS), cystathionine γ-lyase 
(CSE), and cyclooxygenase-1 (COX-1), respectively. They are released from the 
endothelium and act on the adjacent smooth muscle cells to induce relaxation. NO and 
H2S are also produced in smooth muscle cells. AA - arachidonic acid; EDHF - 
endothelium-derived hyperpolarizing factor. Prostacyclin (PGI2) is produced from the 
endothelium through cyclooxygenase-1, and binds to specific receptors in smooth 
muscle cells and activates adenylate cyclase. Thus, increased cAMP levels in smooth 
muscel cells relax the cells ((Wang, 2009)). 
 
 Furchgott and Zawadki (Furchgott & Zawadzki, 1980) demonstrated that 
acetylcholine relaxation in isolated arteries is endothelium dependent. Therefore the 
agent was named endothelium derived relaxing factor (EDRF). Endothelium dependent 
relaxation of blood vessels is produced by several substances (i.e. acetylcholine, ADP, 
bradykinin, histamine etc.). NO stimulates guanylate cyclase of the vascular smooth 
muscle, with the resulting increase in cGMP activating relaxation. Other relaxing 
factors include prostaglandin I2 and endothelium derived hyperpolarizing factor (EDHF) 
(Bassenge & Heusch, 1990; Furchgott & Vanhoutte, 1989; Shepherd & Katusić, 1991). 
Several agents (acetylcholine, bradykinin, histamine, ATP) acting on endothelial 
receptors may release endothelium derives relaxing factors causing vascular relaxation 
(Bassenge & Heusch, 1990; Furchgott & Vanhoutte, 1989) The direct action of these 
agents on smooth muscle cells may cause vasoconstriction. The resulting vascular effect 
depends on the equilibrium of vasodilator and vasoconstrictive effects. If the 
endothelium is damaged vasoconstriction may occur by the stimulation if otherwise 
vasodilator agonists (i.e. acetylcholine) (Bassenge & Heusch, 1990). 
 
Humoral control of veins 
 While both arteries and veins are composed of similar cellular components, there 
are substantial differences. In terms of biological activity of the endothelium arteries 








Figure from David E. Morman Cardiovascular Physiology 8th Edition 
As seen from the figure due to the structural and hemodynamical differences between 
arteries and veins, there are differences in regulations as well. 
 
 During experiments regarding arterial and venous biomechanics usually the 
endothelium-dependent vasodilator response is also tested (Haas et al., 2007). This 
response may be elicited by infusing substances that promote synthesis or release of NO 
from the endothelium. Bradykinin is one of these substances. Venous endothelial cells 
express constitutive B2 kinin receptors. These receptors may be activated by bradykinin 
amongst other substances. These receptors activate phospholipase C, leading to an 
increased level of intracellular calcium, which in turn stimulates NO synthesis. Here, 
the effect of bradykinin enhancing endothelium-dependent vasodilatation through the 
release of NO (Dachman, Ford, Blaschke, & Hoffman, 1993). 
 Previous studies where acetylcholine was administered to elicit endothelium-
dependent vasodilator response demonstrated that high-dose infusions of acetylcholine 
may cause vasoconstriction. There has been more than one study, focusing on the dose-
dependent and endothelium-dependent dilator effect of acetylcholine in veins. They 
suggested that vasodilation mediated by acetylcholine in veins occurs only via NO, 




Several studies have demonstrated that both acetylcholine and bradykinin can be used 
for evaluation of endothelium-dependent venodilation (Rabelo et al., 2008). 
 Alpha 1 adrenoreceptors that have been described to be present in several 
venous segments, such as vena cava, saphenous vein, pulmonary vein etc. promote 
vasoconstriction (Muramatsu, Ohmura, & Kigoshi, 1995). 
 
 
II./3. Biomechanical remodeling of resistance arteries in hypertension, sex 
differences, effects of sex hormones 
 
The effect of hypertension on the geometric and biomechanical parameters of resistance 
arteries.  
 Hypertension is a well established risk factor for several cardiovascular diseases. 
Clinically hypertension is defined as systolic blood pressure higher than 140 mmHg 
and/or diastolic pressure higher than 90 mmHg for systemic arteries (Bergan et al., 
2008).  
 The rise in blood pressure affects the structure and morphology of the vessel 
wall. The mechanical properties and therefore the contractility of the vessels may also 
be altered (Hayashi & Naiki, 2009) 
 Small resistance arteries play a key role in the control of blood pressure. These 
segments are responsible for the most significant decrease of hydrostatic pressure along 
the circulatory system. Peripheral resistance small arteries are defined as having a 
lumen diameter of <350 μm and arterioles as having lumen diameter of <100 μm. These 
two types of vessels are major contributors to total peripheral resistance. According to 
Poiseuille’s law resistance is inversely proportional to the forth power of the radius, 
consequently small changes in lumen - either functional or structural - lead to 
significant alteration in arterial resistance along these vessel segments (Laurent & 
Boutouyrie, 2015; Mulvany & Aalkjaer, 1990; Michael John Mulvany et al., 1996; 
Rizzoni & Agabiti-Rosei, 2012). 
  Living tissue may adapt to mechanical demands by altering structure, geometry 
and biomechanical properties. Mechanical stress is a key factor. In blood vessels the 




direction), wall shear stress caused by blood flow, and axial stress elicited by axial 
elongation (Hayashi & Naiki, 2009).  These forces will induce the long-range adaptive 
processes that affect the geometry (lumen size and wall thickness), tissue composition 
and elasticity of the resistance vessels. In addition, we can not neglect the 
nonhemodynamical neural and humoral effects, which are also altered in case of 
hypertension (epinephrine, norepinephrine, angiotensin II, etc.) 
   
Small Artery Remodeling in Essential Hypertension 
 According to several studies some of the most essential findings in resistance 
arteries in case of essential hypertension are vasoconstriction, eutrophic remodeling 
with increased medial thickness: lumen ratio, altered distensibility and a decrease in the 
vasodilation reserve (Laurent & Boutouyrie, 2015; Mulvany & Aalkjaer, 1990; 
Mulvany et al., 1996; Rizzoni & Agabiti-Rosei, 2012) 
 Increased systemic vascular resistance (SVR), and small artery remodeling are 
typical findings in established essential hypertension (Eftekhari et al., 2012). It has been 
described that small artery structure is predictive of cardiovascular events (Mathiassen 
et al., 2007; Rizzoni et al., 2003). In hypertension, a typical biomechanical 
manifestation of arterial wall adaptation is hypertrophy. This adaptation has several 
advantages. First of all, it restores circumferential wall stress (tangential stress) at in 
vivo operating pressure to a normal value. It also optimizes arterial stiffness (Fridez et 
al., 2001; Hayashi & Naiki, 2009). Through these mechanisms in hypertension arterial 
elasticity is gradually optimized at in vivo working pressures. In hypertension, an 
increase in vascular tone is seen (Fridez et al., 2001; Mulvany & Aalkjaer, 1990). 
Eutrophic inward remodeling may be typical in small arteries (Mulvany, 2008; Mulvany 
& Aalkjaer, 1990, Intengan et al. 1999; Rizzoni & Agabiti-Rosei, 2012). When inward 
eutrophic remodeling occurs, a thickening of the media, a reduction in lumen and outer 
diameter, and increased medial thickness: lumen ratio are seen. This occurs without 
significant alteration to the overall amount of wall tissue or media cross-sectional area 








Figure from (Schiffrin, 2004) 
The cross-sectional area of the media, will remain normal in eutrophic remodeling. 
However in  hypertrophic remodeling. the cross-sectional area of the media will be 
increased. The lumen diameter is decreased in remodeled small arteries, and the 
exterior diameter may be reduced in eutrophic remodeling.  
 
 In eutrophic remodeling, the outer diameter and lumen are both reduced, 
however the cross-section area of the media is maintained. Although the media cross-
section does not undergo hpyertrophy, the smooth muscle cells themselves rearrange 
around a smaller lumen. This in turn leads to an increase in media width. Because the 
lumen diameter is reduced, the media–lumen ratio is increased, which should not be 
confused with hypertrophy (Schiffrin, 2004). 
 
 According to the Laplace-Frank equation (circumferential wall stress, 
σ=MBP×R/h, where MBP is mean BP, R is the radius, and h is the wall thickness), if 
the same amount of wall material is organized around a smaller lumen without net cell 
growth, it is an effective way to normalize circumferential wall stress.  
 In contrast to some types of secondary hypertension, where hypertrophic 
remodeling may be seen, we see inward eutrophic remodeling in the early stages of 
essential hypertension (Rizzoni et al., 2000). As essential hypertension reaches later 
stages, it has been theorized that eutrophic remodeling may turn into hypertrophic 




present a protective mechanism against the rise in blood pressure, thereby preventing 
the rise in circumferential wall stress at the level of arterioles and capillaries which are 
ill equipped to withstand such loads. Another typical finding in essential hypertension is 
a decrease in the vasodilation reserve (the ability to increase blood flow with maximal 
vasodilatation) (Laurent & Boutouyrie, 2015). 
  Vascular smooth muscle cells are activated by hypertension (Hayashi & Naiki, 
2009). Smooth muscle cells play a role in vascular remodeling in hypertension. Along 
with collagen and elastin, smooth muscle cells are cardinal structural elements in the 
vascular wall, and may therefore be essential factors in hypertensive remodeling. The 
changes in vascular tone and contractility seen in hypertension are linked to smooth 
muscle cell activity. Vascular smooth muscle cells are regarded as the sensory and 
effector elements in the adaptation processes, and it is thought that they are activated 
during the early stages of arterial adaptation to hypertension (Schiffrin, 2004). 
  Structural changes along the small arteries are accompanied with changes in 
myogenic tone. At higher pressure loads, increased myogenic tone reduces lumen 
diameter (Izzard, Rizzoni, Agabiti-Rosei, & Heagerty, 2005). This plays an important 
role in the autoregulation of blood flow, and the regulation of capillary pressure. 
 Resistance arteries have the greatest capacity for myogenic response. This 
response to increased circumferential wall stress is inversely related to the diameter of 
the vessel (Allen et al., 1997). This way circumferential wall stress is optimized at 
normal pressure loads (Prewitt et al., 2002). Even though increased wall stress is a 
stimulus for growth, a myogenic response can prevent this process despite an increased 
blood pressure. By preventing growth, eutrophic remodeling is maintained. Therefore in 
case of impaired myogenic tone, as seen in certain types of secondary hypertension, the 
rise in wall stress would not be counteracted, and thus hypertrophy develops (Schofield, 
Malik, Izzard, Austin, & Heagerty, 2002). Therefore, the maintained myogenic 
properties of the vessels play an essential role in determining further structural changes 
in hypertension. Beside altered myogenic tone, vasoconstriction related to chronic 
neurohumoral stimuli (contributing to induction of hypertension) may also play a role in 
the adaptation mechanisms seen in hypertension. 
  As noninvasive ultrasonographic measurement techniques advanced, it became 




smaller vessels (Hayashi & Naiki, 2009), which is a prerequisite for calculating 
biomechanical properties. Significantly larger intimal medial thickness was found in 
hypertensive patients compared to the normotensive group, the internal diameters were 
less affected. Hypertensive patients had an increased ratio of wall thickness to internal 
diameter, increased elastic modulus and lower vascular compliance compared to 
normotensives. There is a decrease in the elastin to collagen ratio which seems to be 
connected with changes of elastic modulus (Berry & Greenwald, 1976). According to 
these studies the restoration of normal wall stress by hypertrophy in hypertension in 
animals may also be observed in human hypertensive patients. 
 There is also a strain hypothesis regarding hypertensive remodeling 
(Takamizawa & Hayashi, 1987), according to altered strain is more important than 
altered stress in inducing the remodeling process (Guo & Kassab, 2004).  Remodeling 
of the ECM adjusting it to elevated myogenic tone of the smooth muscle should explain 
the morphological hypertensive remodeling according to that theory. 
 Coronary microvascular dysfunction characterized by abnormal structure and 
function of the coronaries has been linked to systemic hypertension (Hayashi & Naiki, 
2009). Although several studies have investigated these fields, the pathogenic 
mechanisms underlying coronary microvascular remodeling in hypertension are 
incompletely understood (Mancini et al., 2013). 
 
The role of inflammation in hypertension   
 Hypertension is associated with inflammation; however, whether inflammation 
is a cause or effect of hypertension is not well understood. Human and animal studies 
have suggested that inflammation leads to the development of hypertension, and 
oxidative stress and endothelial dysfunction and other potential proinflammatory 
conditions such as activation of the sympathetic nervous system, aging, and elevated 








Figure from (Dinh, Drummond, Sobey, & Chrissobolis, 2014). 
This figure demonstrates the relationship between inflammation and hypertension and 
the contributing factors involved.  According to this theorem anti-inflammatory drugs 
and statins may be effective antihypertensive due to their anti-inflammatory properties  
 
 CRP can stimulate monocytes to release proinflammatory cytokines such as 
interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumour necrosis factor alpha (TNF-
α) and also endothelial cells to express intracellular adhesion molecule (ICAM)-1 and 
vascular cell adhesion molecule (VCAM)-1. This in effect will further promote 
inflammation.CRP is considered the inflammatory marker with the strongest association 
with hypertension. It has been demonstrated in numerous clinical trials that 
hypertensive patients commonly have increased plasma CRP levels.  
 Experimental studies have focused upon the pathophysiological role of 
individual T-cell subsets, dendritic cells, TNF-α, IL-17, MCP-1, and IL-6, an 
chemokins in hypertension. They have found that innate and adaptive immunity both 
play a significant role in the pathogenesis of hypertension. Specific immune cell types, 
cytokines, toll like receptors, and components of inflammasomes may all pose novel 









Table from (De Miguel et al., 2015). 
Table showing the components of the immune system that may play a role in the 




 A single nucleotide polymorphism in the gene SH2B3 encoding the lymphocyte 
adaptor protein, LNK has been shown to play a role in the development of hypertension. 
Loss of LNK leads to profound inflammation in renal and vascular tissues as well as 
increased IFNγ  leading to hypertension and end-organ damage (Dale & Madhur, 2016).  
 
The role of Angiotensin II in vascular remodeling 
  Angiotensin II is greatly implicated in vascular remodeling of small-resistance 




increased medial thickness to lumen ratio. This may result from a reduced outer 
diameter. In this case the lumen is narrowed without net growth (eutrophic remodeling). 
The media to lumen ratio may also increase, or a thicker media may be formed 
(hypertrophic remodeling). Increased arterial stiffness is a hallmark of structural 
alteration typical of angiotensin II induced hypertension. (Intengan & Schiffrin, 2000; 
Neves et al., 2004; Neves, Virdis, & Schiffrin, 2003) 
 Changes in the extracellular matrix (including collagen type I and III elastin and 
fibronectin) may also be seen. The overall stiffness of the arterial wall depends on the 
ratio between distensible components (elastin) and the less distensible components 
(collagen, fibronectin) (Intengan & Schiffrin, 2000). Elevations in collagen and 
fibronectin content and decreased elastin have been shown in the media of small arteries 
from AngII-infused animals. (Brassard, Amiri, & Schiffrin, 2005; Neves et al., 2004; 
Neves et al., 2003). It has been demonstrated in immunohistochemical and 
histochemical assays that angiotensin II has the ability to increase collagen type I and 
fibronectin content and decrease the amount of elastin in small resistance arteries 
(Brassard, Amiri, & Schiffrin, 2005; Neves et al., 2003) 
 This suggests, that in Angiotensin II induced hypertension smooth muscle cells 
are not the only elements of adaptation, but other cells, such as fibroblasts and/or 
myofibroblasts may play a role in adaptation. The adaptation of the extracellular matrix 
is fundamental in stiffening the arterial wall. Collagen plays a key role in this process, 
as it is found in abundance in the vascular wall. Fibrinectin may accumulate in the 
media of the small resistance arteries. The process of fibrosis may be influenced by 
increased activity of local growth factors such as transforming growth factor β, platelet-
derived growth factor and other growth factors, such as insulin-like growth factor and 
basic fibroblast growth factor. (Intengan & Schiffrin, 2001) 
  Angiotensin II binds to receptors on the vascular smooth muscle cells. 
Angiotensin type 1 receptor (AT1 receptor) is a G-protein coupled receptor, and has 
been described to mediate the cardiovascular effects of angiontensin II (Singh & 
Karnik, 2016). This receptor is predominantly expressed in cardiovascular cells, such as 
vascular smooth muscle cells, and activates various signalling molecules, including G-
protein-derived second messengers, protein kinases and small G-proteins (Higuchi et 




independent β-arrestin, reactive oxygen species, non-receptor type tyrosine kinases, 
small G-proteins, transactivation of receptor tyrosine kinases. Furthermore, interacting 
scaffold, mechanical stress, heterodimerization; and signalling through phosphorylation, 
desensitization, and internalization may also be involved. It has been described that 
non-physiologocal activation of AT1 receptor may lead to a number of pathologies 
including cardiovascular remodeling and hypertrophy, vascular inflammation and 
atherosclerosis, endothelial dysfunction, oxidative stress, extra cellular matrix 
deposition, angiogenesis (Singh & Karnik, 2016).  The AT1 receptor activates tyrosine 
kinases, epidermal growth factor receptor, platelet-derived growth factor receptor, and 
insulin-like growth factor-1 receptor, and nonreceptor tyrosine kinases, such as c-SRC. 
As a result, activation of NAD(P)H (nicotinamide adenine dinucleotide phosphate) 
oxidase may occur, resulting in intracellular generation of reactive oxygen species, 
which influences redox-sensitive signaling molecules, such as mitogen-activated protein 
kinases, transcription factors, and matrix metalloproteinases (Schiffrin & Touyz, 2004; 
Tabet et al., 2008).The attachment of the extracellular matrix to the smooth muscle may 
also be affected via the adhesion molecules that mediate the anchoring of vascular 
smooth muscle cells to ECM components (Intengan et al., 1999).  
 
Sex differences in hypertension 
 Sex differences in hypertension have been described, and are at least in part 
thought to be due to the effects of estradiol and testosterone (Barton et al., 2012). One 
of the effects of testosterone is an increase in angiotensin levels (Yanes et al., 2009). It 
has been described, that vasoconstrictors and vasodilators have different effects in the 
the presence of male and female hormones. Chromosome-linked genetic differences 
have been assumed to be a factor contributing to sex differences in hypertension (Ely et 
al., 2010). Differences have also been reported in therapy and blood pressure control 
(Thoenes et al., 2010).  
 Sex differences in the early stages of hypertensive vascular adaptation in the 
heart and in the intramural small coronary arteries that are fundamentally responsible 
for the blood supply of the heart muscle have not been studied thoroughly. The 
literature is also scarce regarding sex differences in the biomechanical adaptation, and 




angiotensin induced hypertension. Considering that sex differences in cardiovascular 
disease are well documented differences in biomechanical adaptation and alteration of 
the range of pharmacologic reactivity in angiotensin II (AngII) hypertension may also 
be present as well.  
  
The role of sex hormones in hypertension 
 We may conclude that hypertension leads to adverse remodeling and vasomotor 
alterations in coronaries. It is well established that chronic hypertension leads to 
hypertrophic remodeling of the vessel wall, dysfunction of the endothelium, and 
changes in smooth muscle reactivity. The characteristics of remodeling are determined 
by several factors, including hypertensive stimuli, sex, and hormonal effects. 
Alterations in vasoconstriction and/or vasodilation are detectable in most cases (London 
& Safar, 1996; Mulvany, 2002). 
 Following the onset of menopause blood pressure levels increase and become 
similar to those in men suggesting an important role of sex hormones in the regulation 
of blood pressure. This evidence suggests that sex hormones influence the 
cardiovascular system; however, these influences are still poorly understood. Sex 
hormones are able to modulate blood pressure by acting on important systems as 
cardiovascular, renal, and neural. They can have complementary or antagonistic actions. 
For example, testosterone can raise blood pressure by stimulating the renin-angiotensin-
aldosterone system, whereas estrogen has been associated with decreased blood 
pressure. The reduced cardiovascular risk observed in females has been attributed to the 
beneficial effects of estrogen on endothelial function. Estrogens physiologically 
stimulate the release of endothelium-derived vasodilator factors and inhibit the renin-
angiotensin system (dos Santos, da Silva, Ribeiro, & Stefanon, 2014). 
 The role of sex hormones in the development of hypertension in older women is 
still controversial. Some studies in postmenopausal women have shown that transdermal 
hormone replacement therapy reduced mean blood pressure in normotensive women, 
yet, other studies found no effect on resting blood pressure. Studies have shown 
castration to prevent the increase in blood pressure in males and ovariectomy to 
exacerbate the increase in blood pressure in females. It has been suggested that the 




estradiol’s suggested protective effects involve multiple end organs including the 
peripheral vasculature, renal function and brain regions important for central regulation 
of sympathetic outflow. Circumventricular organs are structures in the brain 
characterized by their extensive vasculature and highly permeable capillaries. The 
sensory organs include the area postrema and the subfornical organ. Estradiol inhibits 
firing of neurons in these circumventricular neurons and inhibits their activation by 
circulating peptides. At the level of the nucleus tractus solitarii, estradiol can directly 
modulate neuronal activity, baroreceptor afferent information integration and ultimately 
arterial baroreflex function. Estradiol also has effects on sympathetic pre-motor neuron 
drivers and is able to inhibit the activity of these neurons involved in driving 
sympathetic outflow. The inhibition of the neurons may be how estradiol protects from 
some forms of neurogenic hypertension. Estrogen may also act to modulate gene 
function and protein expression of specific proteins such as the AT1 receptor and NOS 
(Hay, Xue, & Johnson, 2014).  
 Experimental studies on sex differences in the developmental programming of 
hypertension indicate that development insults exert sex-specific programming of 
nephron number and blood pressure in males and females. The exact mechanism(s) 
involved remain unclear, but appear to be multi-factorial. Potential mechanisms by 
which a developmental insult differentially programs the long-term control of blood 
pressure may be due to the influence of the hormonal milieu on the renin angiotensin 
system, due to innate sex differences in production of reactive oxygen species or 
endothelin, or impacted by increased susceptibility that occurs with age and the 
development of age-dependent increases in adiposity leading to activation of the 
sympathetic renal nerves. The fetus also exhibits innate sex differences in expression of 
the intrarenal renin angiotensin system which may or may not reduce nephron number. 
(Ojeda, Intapad, & Alexander, 2014). 
 The role of androgens in cardiovascular risk is not clear. There are observations 
that suggest that androgen deficiency in man might contribute to the development of 
cardiovascular disease and hypertension. Epidemiological studies have found that there 
is a high prevalence of low testosterone levels in men with coronary heart disease.There 




protective effects on cardiovascular and may play important roles in the acute regulation 
of vascular function. Some studies have demonstrated that testosterone exerts beneficial 
effects on cardiovascular function by inducing rapid vasorelaxation of vascular smooth 
muscle(dos Santos et al., 2014). 
 Testosterone deficiency has been shown to increase cardiovascular risk, as well 
as testosterone having been shown to increase cardiovascular risk. Among the men with 
testosterone levels under 300ng/dL an increased risk of heart attack and strokes in men 
who received testosterone prescriptions compared to those who didn’t (Miner, Barkin, 
& Rosenberg, 2014). 
 The specific effects of hypertension on intramural coronaries in women has been 
documented in one of our previous studies (Mátrai et al., 2010) however, little is known  
the intramural coronary arteries in the left ventricle are of the utmost importance 
concerning target organ damage in hypertensive and ischemic heart disease. It is 
technically demanding to dissect these coronary branches, which may contribute to the 
fact that there is more data available on peripheral branches and epicardial coronaries 
(Schiffrin, Park, Intengan, & Touyz, 2000). Intramural arteries are rarely investigated in 
vitro (Nádasy et al., 2001). 
 Compared with epicardial coronaries intramural vessels demonstrate unique 
flow conditions. This is hypothesized to be the effect of the characteristic vascular bed 
created by the muscle environment (Toyota et al., 2005). 
 The effects of ovariectomy and estrogen therapy on vascular remodeling have 
been reported in normotension (Mericli et al., 2004). As women have been shown to be 
less vulnerable to cardiovascular risk, it is fair to hypothesize that hormones such as 
estrogen may help counterbalance some of these effects. There is minimal data available 
on the effects of ovariectomy and estrogen therapy in menopausal hypertension induced 






II./4. The effects of  venous hypertension on the geometrical and biomechanical 
characteristics of the venous wall.  
  The endothelial cells are subjected to shear stress of the flow, which is also 
much less in veins than in arteries. As we have stated above, living tissue may adapt to 
mechanical demands by altering structure, geometry and biomechanical properties. 
Mechanical stress is a key factor. In blood vessels the most relevant stresses are: 
tangential stress induced by blood pressure (circumferential direction), wall shear stress 
caused by blood flow, and axial stress elicited by axial elongation. (Hayashi & Naiki, 
2009) Gaining information regarding how cells recognize different levels and modes of 
stress and how they respond to these may be a significant step in understanding vascular 
adaptation mechanisms.  Endothelial cells, for example used to be considered a uniform 
passive cell population serving as a physical barrier between blood and tissue, now they 
are recognized to be quite “heterogeneous”. Endothelial cells may differ widely in 
morphology and function along the vasculature. Endothelial cells of the resistance 
arteries or arterioles are longer and narrower than those in small veins or venules. One 
of the major roles of arteriolar endothelial cells is the control of vascular tone, whereas 
post-capillary venular endothelial cells are the primary site of leukocyte trafficking. 
While arterial endothelial cells are long and narrow or ellipsoidal,as is appropriate of 
their alignment in the direction of blood flow, venous ones are short and wide, as blood 
flow rates in the venous circulation are significantly lower than in the arterial 
circulation. Shear stressen differ in the arterial and venous segments as well. 
Physiological venous and arterial shear stress levels are typically 1–5 dynes/cm2 and 
10–40 dynes/cm2, respectively (dela Paz & D'Amore, 2009). 
 Depending on the type and magnitude of stress, endothelium responds to shear 
stress through various mechanisms. Exposure of vascular endothelium to shear forces in 
the the normal value range stimulates endothelial cells to release agents such as 
prostacyclin, NO, calcium, thrombomodulin etc. How the mechanical forces are 
detected and transformed into signals that stimulate intravascular processes remains is 
not yet described. Models of mechanotransduction included a localised model, where 
the mechano-receptor, is considered to be located in cellular membrane. Possible 




may respond to shear stress alteration. Another model is the decentralised model, where 
shear stress forces acting on a cell’s surface are transmitted through a cytoskeleton, 
allowing the activation of several mechano-receptors within the cell. Integrines 
connected with cytoskeleton have been related to this ofrm of emchanoception 
(Papaioannou & Stefanadis, 2005).  
 As we have seen earlier, hypertrophy is a typical vascular adaptation to 
hypertension. This has several advantages, i.e. restoration of circumferential wall stress, 
optimizing arterial stiffness (Hayashi & Naiki, 2009). Similar alterations may also occur 
in the venous wall. 
  Venous hypertension appears in chronic venous diseases, i.e. valvular 
dysfunction, iliofemoral deep vein thrombi. In these cases venous hypertension is 
accompanied by varicosities, edemas, pigmentation etc. Chronic venous insufficiency is 
a combination of reflux and obstruction. 
Neglén (Neglén & Raju 1995) observed that the femoral and popliteal veins, which are 
exposed to venous hypertension in the patient and have venous insufficiency due to 
reflux/obstruction, were less compliant, than those seen in healthy patients. Monos et al,  
(Monos, Contney, Cowley, & Stekiel, 1989; Monos et al. 2007) studied the 
biomechanical effects of chronic venous hypertension. The venous hypertension was 
induced by exposing rats to a head up tilt for 2 weeks, pressure-diameter relations and 
wall thickness were studied in vitro using videomicroscopy and angiometry. In the head 
up tilt group the outer diameter increased, and wall distensibility decreased compared to 
the non-tilt group. No difference was found in wall thickness between the groups. 
Augmented myogenic response, with increased mass of the venous smooth muscle cells 
in the venous wall due to increased passive diameter were found. Hayashi (2003) 
induced venous hypertension in the femoral vein in rabbits, by constriction of the 
external iliac vein. Biomechanical properties of the femoral vein were studied. In 
venous hypertension after one week wall thickness was increased thereby 
circumferential wall stress decreased to control level. Stress was kept at normal up to 4 
weeks. In venous hypertension, vascular tone contractility increased, while elasticity 
and compliance remained normal. These results are reminiscent of those seen in arteries 




operate against hypertension. Monos et al. found (Monos & Csengödy 1980), that 
venous arterialization occurs in venous grafts as adaptation to elevated blood pressure. 
After ligation of the left anterior descending coronary vein in swine, (Choy, 
Dang, Molloi, & Kassab, 2006) found that wall area and wall thickness to radius ratio 
increased significantly due to venous hypertension. Due to the fact that the vessels are 
embedded in the myocardium to a certain degree, the remodeling was circumferentially 
and axially nonuniform because it is tethered to the myocardium to different degrees. In 
this case, the remodeling served to restore circumferential wall stress to normal levels 
(Hayashi & Naiki, 2009). To retain wall stress at normal levels in chronic hypertension 
wall thickening, increase in vascular tone and contractility occur. These remodeling 
phenomena in veins are similar to those observed in arteries exposed to hypertension. 
(Hayashi & Naiki, 2009; Raffetto & Khalil, 2008). 
 It has been shown, that venous hypertension plays a role in the pathogenesis of 
varicose veins (Raffetto & Khalil 2008). Increased expression of matrix 
metalloproteinases has been demonstrated in varicose veins. Matrix metalloproteinase-2 
reduces the contraction ability of the vein. The exact relation between venous pressure, 
MMP expression and venous dysfunction is unclear. It has been proposed, that chronic 
venous hypertension leads to an overexpression of matrix metalloproteinases and 
decreased contractility, which in turn promotes venous dilation. (Raffetto & Khalil, 
2008) Even less is known on the effect of altered flow on venous remodeling. (Hayashi 
& Naiki, 2009) 
  
   II./5.Mechanisms leading to the development of varicose veins 
  Varicosity is a common pathology on the lower extremities. Clinically it is 
usually characterized by excessive dilation and tortuousity of the subcutaneous venous 
system (Aunapuu & Arend, 2005). The primary cause for development of varicosity has 
been thoroughly studied, but not yet established. Evidence from the literature suggests 
that vein valve dysfunction and hydrostatic venous pressure play a significant role in the 
development of this disease (Raffetto & Khalil, 2008). Valve-reflux has been 
demonstrated to precede venous dilatation (Schultz-Ehrenburg, Weindorf, Matthes, & 




reflux, and it has been suggested that valvular dysfunction may be an epiphenomenon of 
venous dilation (Gandhi et al., 1993; Kirsch et al., 2000; Raffetto & Khalil, 2008). 
 There seems to be a consensus that one key factor in the development of 
subcutaneous venous varicosities is chronically elevated venous pressure in the lower 
extremities. Such arises due to gravitational effects determined by lifestyle and will be 
further exaggerated by valvular incompetence. Flow disturbances, inherited connective 
tissue weakness, obesity and local inflammation contribute to the pathomechanism. 
(Bergan et al., 2008; Fegan & Kline, 1972; Gemmati et al., 2009; Lee, Evans, Allan, 
Ruckley, & Fowkes, 2003).  
 There is data to suggest that alterations in the extracellular matrix proteins may 
lead to connective tissue changes prior to valvular insufficiency (Gandhi et al., 1993). 
Certain matrix metalloproteinases (MMP-1, -2, -3, -9, -12 and -13) have been 
demonstrated  an increase in  expression / activity in the venous wall and in the plasma 
of patients with varicose veins (Jacob et al., 2002; Woodside et al., 2003). The 
expression of MMP-1 and -9 has been demonstrated not only in the adventitial 
fibroblasts, but in the medial smooth muscle and in the endothelial cells also (Woodside 
et al., 2003).  A significant increase in MMP-1, -2, and -9 has been found in varicosity 
patients, where thrombophlebitis developed. These alterations in the level of matrix 
metalloproteinases may lead to remodeling of the extracellular matrix, and thereby 
inducing alterations in the mechanical properties of the vein wall. These mechanisms 
may play a role in progression of the disease (Kowalewski et al., 2004). Increased 
expression or matrix metalloproteinase-2 may occur in response to mechanical 
stretch/pressure on the endothelium (Milkiewicz & Haas, 2005). 
  
II./6. Development of varicose veins, biomechanical alteration in varicosity 
 Depending on the population studied, (differences include: age, race and gender, 
methods of measurement and disease definition) the prevalence of varicose veins may 
reach 56% in males, and 73% in females (Beebe-Dimmer, Pfeifer, Engle, & 
Schottenfeld, 2005; Robertson, Evans, & Fowkes, 2008). The definition of the disease 
in these studies ranges from self reporting by the study participants, or patient recall of 
their diagnoses to standardized physical examination. The Framingham Heart Study 




vs.1.9%) (Raffetto et al., 2010).The San Diego Population Study was a cross-sectional 
study of 2,211 men and women from different ethnical backgrounds, and it showed 
varicose veins in 28% of the adult female population compared with in 15% of the adult 
males (Raffetto et al., 2010) 
 The veins in the affected region become dilated and tortuous (Aunapuu & 
Arend, 2005). Signs of degeneration may be observed in the vein wall (Stauffer et al., 
2010). Diabetes, obesity, smoking and age have been implicated as risk factors for the 
development of varicose veins. It has not been established what the primary cause is in 
the development of lower limb varicosity, but vein valve dysfunction an hydrostatic 
venous pressure have been implicated as major contributing factors to this to the 
progression of this disease (Pascarella & Schönbein, 2005; Raffetto & Khalil, 2008; 
Raffetto et al., 2010). 
 Gravitational stress, hemodynamic disturbance (Fegan & Kline, 1972) genetic 
factors, (Molnár et al., 2013), local inflammation, (Woodside et al., 2003) have been 
implemented in the development of varicose veins. The pathomechanisms underlying 
the development of varicose vein is still inconclusive. 
 Age and pregnancy have been shown to be definite risk factors for varicosity 
Genetic link and past history of deep vein thrombosis are supported by good evidence 
as risk factors for varicosities (Wright & Fitridge, 2013). However the evidence 
regarding other risk factors is not conclusive. The difficulty with study design regarding 
prolonged standing is exact measurement criteria, though Working in a standing 
position has been shown to be associated with subsequent hospitalization due to 
varicose veins for both men and women (Tüchsen, Krause, Hannerz, Burr, & 
Kristensen, 2000). Other implicated risk factors include prolonged standing, obesity, 
diet, smoking, etc. Obesity, which has been proposed to be a primary cause of lower 
limb varicosity has been shown to be an aggravating factor only by some studies (Lin, 
Zhang, Sun, Ren, & Liu, 2015; London & Nash, 2000). The development of varicose 
veins is commonly attributed to vessel wall degeneration (Rooke & Felty, 2014). 
Regulatory genes of mediators of the inflammatory reaction and collagen production 
have been shown to be up-regulated and down-regulated, respectively in patients 
suffering from chronic venous insufficiency (Markovic & Shortell, 2013). Venous 




as hypoxia activated leucocytes and endothelium lead to the release of mediators 
regulating vein wall remodelling similar to those observed in varicosities (Lim, Gohel, 
Shepherd, Paleolog, & Davies, 2011). 
 More unusual secondary causes of varicosities may include traumatic arterio-
venous fistul, iliac vein thrombosis, Klippel Trenaunay syndrome, and another suffered 
arterio-venous malformations (Bhatti et al., 2013). Some articles suggest that the 
development of varicose veins insufficiency is preceded by and associated with the 
remodelling of the venous wall. They emphasize that a rise in venous pressure is 
sufficient to promote varicose remodelling of veins by augmenting wall stress and 
activating venous endothelial and smooth muscle cells (Pfisterer, König, Hecker, & 
Korff, 2014). There is evidence to support that there is an association between higher 
estradiol levels and varicosity or increased venous distensibility(Ciardullo et al., 2000). 
Estradiol/free testosterone ratios were studied in men and result suggest that 
estradiol/free testosterone ratio is associated with varicose veins in male patients . 
 Others suggest that varicose veins result from failure of valves in the superficial 
veins leading to venous reflux and vein dilatation is superseded by the hypothesis that 
valve incompetence follows rather than precedes a change in the vein wall. This in turn 
would mean that tha vein wall has inherent structural weakness in varicose veins, which 
leads to dilatation and separation of valve cusps so that they become incompetent. The 
fact that dilatation of varicose veins is initially distal to the valve supports this theory 
(London & Nash, 2000). Intimal thickness, intimal fibrosis, and total thickness and 
intimal/total thickness ratio were highest in venous clinical severity score 0, 1 in chronic 
venous insufficiency, suggesting that the vessel wall undergoes changes before varicose 
veins become apparent (Dhanarak & Kanchanabat, 2016). It has been described in 
several articles that valve-reflux preceeds dilatation, (Schultz-Ehrenburg, Weindorf, 
Matthes, & Hirche, 1992), while in other publication the opposite sequence has been 
show. (Gandhi et al., 1993; Delia Kirsch et al., 2000; Kirsch, Wahl, Böttger, & 
Junginger, 2000; Raffetto & Khalil, 2008). Our opinion is that valve insuficciciency will 
induce dilation and valve incompetence in the retrograde direction while flow induced 
fast dilation can be an other reason of dilation with valve insufficiency. There are 
clinical studies in the literature that describe venous insufficiency occurring without 




is also evidence to support the fact that alterations in the extracellular matrix, i.e. in the 
extracellular matrix proteins may precede valve insufficiency (Gandhi et al., 1993) 
Studies have also confirmed alteration in matrix metalloproteinases in the venous wall 
of patients suffering from varicosities.  
 We may state that substantial biochemical alterations occur in the varicous vein 
wall. Susceptibility of the venous wall for stretching is strongly dependent on smooth 
muscle cells and connective tissue fibres content of the vessel wall. 
 Vascular smooth muscle cells are highly specialized cells, that contract and the 
produce the extracellular matrix components of the vessel wall. Smooth muscle cells in 
the vessel wass express a range of contractile proteins, ion channels and signaling 
molecules. Depending on circustances a variety of smooth muscle cell phenotypes may 
be found. Previous studies have distinguished the spindle-shaped contractile and 
epithelioid-shaped synthetic and proliferative phenotypes (Chen, Qin, Wang, & Zhang, 






Prolifetive and contractile subtypes of smooth muscle cells 
  
 
 Varicose veins have thickened vessel walls, considered to be the result of the 
dysregulation of the synthesis of extracellular matrix proteins.NELIN is an F-actin-
associated protein found in veins. The protein mediates cell motility and is important in 
the process of cell migration and adhesion. SM22α is a calponin-related protein ans is a 




varicose vein, it was concluded that varicose vein smooth muscle cells transformed 
from a contractile to a synthetic phenotype with varicosity (Chen et al., 2015). 
 There is also evidence from clinical studies showing, that venous insufficiency 
may occur without axial reflux (Labropoulos et al., 1999).  
 Incompetent venous valves lead to reflux, and this mechanism has been 
portrayed as a major contributor to many phenomena seen in chronic venous 
dysfunction (Bergan et al., 2006). Stretching, thinning and tearing of the valves have 
been described. Some studies found hypertrophy and alterations in collagen and the 
endothelium in chronic venous disease (Corcos et al., 2000). In this kind of patient, the 
number of valves in a given segment may be reduced, and degeneraed valve stumps 
may appear (Ono, Bergan, Schmid-Schönbein, & Takase, 1998). Depending on the 
population studied, (differences include: age, race and gender, methods of measurement 
and disease definition) the prevalence of varicose veins may reach 56% in males, and 
73% in females (Beebe-Dimmer, Pfeifer, Engle, & Schottenfeld, 2005; Robertson, 
Evans, & Fowkes, 2008). 
 Experiments centered on inducing venous hypertension showed that reduced 
flow may trigger inflammatory processes such as adhesion of leukocytes to the 
endothelium and increase in free radicals. Under normal flow conditions shear stress 
induced by blood flow, acting through the endothelium may inhibit inflammatory 
processes, through several mechanisms (Garin & Berk, 2006). In an 
atherosclerosismodel physiologic fluid shear stress has been demonstrated to decrease 
TXNIP (Thioredoxin-Binding Protein) expression. This results in increased TRX 
(Thioredoxin) binding to ASK1 (Apoptosis signal-regulating kinase 1). This in turn 
inhibits cytokine activation of the JNK (Jun N-terminal kinase) pathway. JNK plays a 
critical role in death receptor-initiated extrinsic as well as mitochondrial intrinsic 
apoptotic pathways. In turn such proinflammatory events such as VCAM1 (Vascular 
cell adhesion protein 1) expression wil be prevented. This shows that normal flow 
prevents the activation of inflammatory pathways. Inhibition of mitogen-activated 
protein kinase inflammatory pathways reduction in the expression of adhesion 
molecules and activation of antioxidant mechanisms have also been described. (Chiu et 
al., 2003). Shear stress may also act not only through the endothelial cell, but also 




molecules such as CD18 as well as detachment of leukocytes from the endothelial wall. 
This explains how low-flow conditions and reduced shear stress may trigger processes 
of inflammation (Bergan et al. 2008). 
 However histological evidence of macrophage invasion, and new cell formation 
in association with a newly developed venous collateral system is hard to come by in 
the literature. 
 In the vein ligation model, where venous hypertension was created by ligating a 
large venous branch demonstrated that elevation of pressure in the vein lead to an 
increased number of leukocytes in and around the venous wall (Hahn et al., 2000). 
 Experimental elevation of venous pressure in the leg was achieved in our 
laboratory by keeping rats in tilted tube-cages for a chronic period, which doubled 
venous pressure and resulted in several massive cytophysiological alterations (Lóránt, et 
al., 2003; Monos, Bérczi, & Nádasy, 1995; Monos et al., 1989; Monos et al., 2007; 
Raffai et al., 2008) in the venous wall. However, applied alone, it failed to induce 
varicous morphological remodeling (Lóránt et al., 2003). Meanwhile, a wider use of 
Duplex scan and high resolution ultrasonographic devices in phlebological practice 
revealed a substantial flow disturbance in the majority of varicous networks. (Delis, 
2005; Labropoulos, Tassiopoulos, Bhatti, & Leon, 2006)  
 From the above we may conclude that there is evidence to suggest that chronic 
flow alterations induce morphological remodeling processes in the affected vessels 
(Baeyens & Schwartz, 2016; Carmeliet, 2005; Dumont, Loufrani, & Henrion, 2007). 
Unfortunately, despite the emerging significance of flow disturbances in the 
development of pathological varicose morphology, there is a lack of experimental 
studies addressing the flow induced remodeling processes of the venous side of the 
circulation. 
The role of inflammation in the development of venous network collaterals  
 Experiments focusing on the induction of venous hypertension by creating an 
arterio-venous fistula showed that this leads to an immediate increase in venous 
pressure and the dilation of the veins affected by the created fistula. The appearance of 
reversed flow did not occur immediately but through the course of several weeks. 
Progressive alterations in valve morphology were also observed including 




subjected to increased pressure had an increased number of granulocytes, 
monocytes/macrophages, and T-lymphocytes, and elevated levels of inflammatory 
markers. Over the course of several weeks, alteration in the venous structure such as 
thickening of the wall and fibrosis were also observed (Bergan et al., 2008). As 
previously seen in the previous occlusion model, there is evidence in these venous 
hypertension models as well, that normal blood flow conditions (laminar flow, 
unidirectional) act as an anti-inflammatory trigger through the endothelial cells, If flow 
decreases, becomes turbulent, or changes its direction, it  may trigger an inflammatory 
response (Li, Haga, & Chien, 2005). Increased pressure itself has been described to 
have a pro-inflammatory effect (Pauletto & Rattazzi, 2006). Triggered by increased 
pressure and decreased flow, the venous valve may show signs of histological changes. 
The inflammatory response may lead to structural weakness and damage of the venous 
valves (Bergan et al., 2008; Hahn et al., 2000). 
 Recent evidence suggests that processes of inflammation and angiogenesis are 
interconnected, especially in human pathologies. This may be one of the mechanisms 
that play a role in the development of venous network collaterals. While research 
typically focuses on understanding and exploiting the role of angiogenic factors and 
vascular cells on new blood vessel formation, the activity of the immune system is 
being increasingly recognized to impact vascular formation and adaptation (Kwee & 
Mooney, 2015). Newly formed blood vessels enable the continuous recruitment of 
inflammatory cells, which release a variety of proangiogenic cytokines, chemokines, 
and growth factors and further promote angiogenesis. Recently, this concept of 
reciprocity of angiogenesis and inflammation has been expanded to include oxidative 
stress as a novel mechanistic connection between inflammation-driven oxidation and 
neovascularization. Pathological angiogenesis appears to be closely associated with 
inflammation and inflammation-generated oxidative stress. A number of inflammatory 
cells, including neutrophils, eosinophils, mast cells, natural killer cells, macrophages, 
and dendritic cells, are involved in inducing and promoting angiogenesis (Kim, West, & 
Byzova, 2013). 
 As we see the extracellular martix of the vessel wass is significantly altered in 
varicose veins. The expression and the activity of matrix metalloproteinase 1, -2, -3, -9, 




increase in matrix metalloproteinase 1 and 9 has been shown to increase not only in the 
fibroblasts of the adventitia but in the smooth muscle cells of the media and in the 
endothelium also (Woodside et al., 2003). Evidence suggests that matrix 
metalloproteinase -1-2 and 9 are significantly elevated in the venous wall affected by 
varicosity and thrombophlebitis. It has also been suggested that this increase in matrix 
metalloproteinases leads to significant remodeling of the extracellular matrix of the 
wall, which in turn may alter the biomechanical characteristics of the venous wall 
(Kowalewski et al., 2004). Matrix metalloproteinases may therefore contribute to 
progression of venous disease. 
Inflammatory processes have been described to play a role in the development or 
varicose disease. Acute and chronic inflammation is associated with changes in 
microvascular morphology and function.  Under physiological conditions endothelial 
cells maintain a nonthrombogenic, nonreactive surface at the interface between blood 
and tissue. Should proinflammatory mediators be triggers, the endothelium may be a 
majot contributor in the generation of the inflammatory response (Pober & Sessa, 
2014). In animal models venous hypertension was induced by venular occlusion/ligation 
and creation of an arteriovenous fistula. The data from these studies suggest that 
inflammatory process may be triggered by the alteration of flow and pressure in the 
venous system.  Inflammatory processes may lead to valve insufficiency characteristic 
in venous disease (Bergan et al. 2008). Studies have revealed that proteinases released 
by inflammatory infiltration cells, may be responsible for the venous wall hypertrophy. 
Inflammatory infiltration cells lead to the activation of matrix metalloproteinase 
activation and dissolution of collagen in theextracellular matrix. Endothelial cells may 
also be activated, and may release transforming growth factor-β (TGF-β), which leads 
to the migration of smooth muscle cells proliferation and migration into the intimal 
layer. There is some evidence to suggest that altered hemodynamics and abnormal 







II./7. Morphology, geometry and the development of network collaterals 
 With improved ultrasonographic devices in clinical use, more significance is 
attributed to blood flow alterations, preceeding or accompanying chronic venous disease 
of the lower extremities in addition to pressure changes. Animal experiments  showed 
that occlusion of the auricular vein in mice led to alteration in vein morphology 
resembling the early stages of varicosity in humans (Pfisterer, König, Hecker, & Korff, 
2014). The branching patterns, geometry and morphological alteration of the vascular 
system are quite complex. There is morphometric data in the literature regarding the 
vascular trees of several segments i.e., coronary, pulmonary, skeletal muscle vessels, 
mesentery, omentum, and conjunctiva. It would appear based on these studies, that 
these biological trees obey a set of scaling laws that are based on the hypothesis that the 
cost of construction of the tree structure and operation of fluid conduction should be 
minimized (Hahn et al., 2008). Blood, air, urine, bile etc. is conducted within the body 
structures by channels forming „biological trees”. Energy expenditure is necessarily 
required for the conduction of any of the above through the biological tree structure. 
There are frictional losses along the route. When the branches of the biological tree 
have greater diameters, these frictional losses may be minimized.  
 There is of course an energy cost associated with the construction and 
maintenance of a large diameter branch (Aunapuu & Arend, 2005; Revellin, Rousset, 
Baud, & Bonjour, 2009) Muray described a compromise between frictional and 
metabolic cost expressed as cost function. Murray’s law is the formulation of the 
minimum energy hypothesis. Murray’s law is expressed as: Q= kD
3
 where Q and D are 
volumetric flow rate and diameter of a vessel segment, respectively, and k is a 
proportionality constant. Murray’s law proposes a universal, invariant exponent of 3.0 
for all trees, where flow along the course of the tree structure is laminar. It has been 
proposed (Kassab, 2006) that this constant may vary between 2.33–3.0 depending on 
whether the flow is turbulent (2.33) or laminar (3.0). 
   Genetic programming plays a cardinal role in the development and design of 
biological trees. This genetic program may, however be influenced by many 
environmental factors. These factors are often related to the particular biological needs 




geometric alterations and remodeling along these biological trees may be seen. The 
changes observed along the course of the branches may be indicative of the functional, 
biological or metabolic demands affecting the tissues. This may be seen as adaptation to 
the environment and a selection and the survival of the valuable tree structure design. 
The factors determining geometric design are multiple. It may be stated that Murray’s 
law may not be applicable to many biological trees in the human body. Therefore an 
extension of Murray’s law has been proposed, where the exponent is not a universal 
constant (Kassab, 2006; Revellin, Rousset, Baud, & Bonjour, 2009). As blood is 
composed of multiple components, it has complex rheological characteristics. It has 
been demonstrated that blood may be considered a non-Newtonian fluid, as it 
demonstrates such characteristics as shear-thinning, viscoelasticity, yield stress, etc. 
Evidence suggests that the vascular system remodels to maintain wall shear stress 
within a physiological range (Revellin, Rousset, Baud, & Bonjour, 2009). This theory is 
based on Murray’s law, which underlines the principle of minimum work and states that 
the third power of the radius of the parent vessel is the same as the sum of the third 
power of the radii of the daughter vessels. 
 The laws that govern the development of vascular tree structures include scaling 
relationships between length and overall vascular volume of the tree; lumen diameter 
and blood flow conditions in the branches; diameter and length of the vessel branches. 
(Hahn et al., 2008) It is required by Murray’s law that the exponent of the diameter-flow 
rate relation be equal to 3.0, but in the case of vascular trees, the ratio of metabolic to 
viscous power dissipation of the tree of interest also plays a role (Kassab, 2006). 
 The literature is scarce regarding documentation of newly developed bypassing 
collaterals that formed as a result of the stricture and the highs pressure-low flow 







III. Aims of study 
 
The vasculature is no longer regarded as a network of elastic tubes, but a complex, 
highly sensitve and highly adaptive system.Biomechanical remodeling may occur as a 
consequence of many factors (hemodynamic, endocrine and others), and the remodeling 
itself may be varied. Our aim was to study hemodynamic and endocrine factors in the 
biomechanical remodeling of the vascular wall. Our intention was to focus on vessel 
wall remodeling in diseases that have a large adverse impact on the well-being of the 
population. Therefore our research centered on coronary pathologies in hypertension 
and the possible effects of sex hormones of coronary pathologies. The other field 
chosen was the development of varicosities. Coronary pathology in hypertension and 
varicosities are widespreaddiseases and deeper understanding of underlying 
mechanisms may contribute to more targeted therapeutic options in the future 
 
The following questions were intended to be answered by this study: 
 
III./1.Is there a difference between the sexes regarding vascular remodeling in the 
coronary resistance arteries of the rat following AngII induced hypertension? 
   
III./2.  How does ovariectomy and hormone replacement affect this remodeling in 
the intramural coronaries, which play a cardinal role in cardiovascular 
pathophysiology? 
  
III./3. How does the increase in venous pressure and decrease of venous flow effect 
the geometrical and biomechanical characteristics of the saphenous vein main 
branch in chronic main branch stricture model in rats? 
  
  III./4. Is there evidence of collateral network formation following partial clipping 
 of the main branch of the saphenous vein of the rat? 
 
  III./5. Is there evidence of macrophage invasion and new cell formation at the 






For better cohesion, we start this section with a summary table of the experiments 
performed (Table 2.). 
 
Table 2.  
Summary table of animals.  First series included chronic Angiotensin II infused, 
Sprague Dawley rats male vs. female, and the left descending coronary was studied via 
angiometry under the induced hypertensive conditions. The second series included 
chronic Angiotensin II infused Sprague Dawley rats, where one group was 
ovariectomized, one group was ovariectomized and given estrogen therapy, and the 
third, “control hypertensive group” underwent a sham abdominal operation, the left 
descending coronary was studied via angimoetry under the induced hypertensive 
conditions. In the third series, the saphenous vein, and it’s tributaries were studied in a 
low-flow high-pressure model. Videomicroscopy studies were performed on the first 
group, hemodynamic measurements were made on the second group. The third group 
underwent preparation with Batson#17 Corrosion Kit, and plastic casts were prepared 
to study the developed vanous collateral system. The fourth and firth group were 
sacrificed at 4 and 8 weeks respectively and angiometry was performed. Histopathology 









  IV./1. Chronic Angiotensin II infusion  
 Chronic Angiotensin II was used used in a study designed to gain a deeper 
understanding of the sex differences in the early mechanisms of vascular adaptation of 
the intramural small coronary arteries. The protocol for angiotensin-dependent 
hypertension has been reported in detail (Várbíró et al., 2001; Várbíró et al., 2000). 
Previous studies reported that this subcutaneous dose led to chronic blood pressure 
elevation after 2 to 3 weeks without acute pressure effects, which is why we chose this 
model to study early hypertensive vessel alterations and sex differences. An osmotic 
minipump was implanted into Sprague-Dawley rats (Figure 12).  The osmotic 
minipump implanted was from Alzet (2ML4, Durect Co, Cupertino, California) 
containing AngII acetate (Sigma-Aldrich Co, St. Louis, Missouri and Budapest, 
Hungary). Pentobarbital (Nembutal®, Phylaxia-Sanofi, Budapest, Hungary) was used 
for anesthesia. After surgical intervention, long-term 100,000 IU of penicillin (TEVA-
Biogal® (Retardillin, TEVA-Biogal, Debrecen, Hungary) was administered 
intramuscularly to prevent infection. The pump remained in situ for 4 weeks, infusing a 
dose of 100 ng/kg/min Angiotensin II acetate. Four weeks later, the animals were 










 The left coronary branch, which is fundamentally responsible for the blood supply of 
the heart was chosen to be studied. The pharmacologic reactivity and biomechanical 
properties of the dissected and isolated left anterior descendent coronary (approximately 
200µm in diameter) branches were cannulated with plastic microcannulas at both ends, 
and studied in vitro in a vessel chamber (Figure 13.). The inner and outer diameter of 
the coronaries were measured by microangiometry, and spontaneous tone, wall 
thickness, wall cross-sectional area, tangential stress, incremental distensibility, 
circumferential incremental elastic modulus, thromboxane agonist-induced tone, and 





Figure 13.  
Vessel chamber and tissue bath set-up used for microangiometry. Images from the 





Sex differences between Male vs. Female Animals 
 A total of 20 sexually mature, 2-month-old, age matched Sprague-Dawley rats 
were used (10 virgin females and 10 males; Charles River Laboratories, Wilmington, 
Massachusetts), weighing 220 to 250 g (females) and 280 to 320 g (males) at the 
beginning of the study. The females and males were both subjected to subcutaneous 
implantation of an osmotic minipump performed as described above.  
 No medical or surgical complications were observed. Conventional rat chow and 
tap water were provided ad libitum. The investigation conformed to the Principles of 
Laboratory Animal Care National Institutes of Health publication No. 85-23 (revised 
1985) with the Euroconform Hungarian Law on Animal Care (XXVIII/1998) and was 
approved by the institutional Animal Care Commission (institutional review board 
approval: 22.1/2960/003/2009).  
 
Ovariectomy and estrogen therapy  
 We designed a study to analyze the effects of ovariectomy and estrogen therapy 
in a rat model of menopausal hypertension induced by angiotensin II (AngII). A total of 
33 sexually mature, virgin female Sprague- Dawley rats were used (Charles 
RiverLaboratories, Wilmington, MA, Semmelweis University Budapest), weighing 210 
to 240 g at the beginning of the study. All of these rats were subjected to subcutaneous 
implantation of osmotic minipump as described above- We investigated intramural 
coronaries taken from ovariectomized rats (n=11) that received chronic AngII treatment 
to induce hypertension, and compared the results with those found in rats that were also 
given estrogen therapy following the ovariectomy (n=11). The ‘‘hypertensive control’’ 
group (n=11) underwent an abdominal sham operation, and received AngII.  
 No medical or surgical complications were observed. Conventional rat chow and 
tap water were provided ad libitum. The investigation conformed to the Guide for the 
Care and Use of Laboratory Animals published by the US National Institutes of Health 







  IV./2. Partial chronic occlusion (‘‘clipping’’) of the saphenous vein in the rat 
 We designed a study to better understand factors that play a role in the 
development of varicosities. We induced a combined flow-pressure disturbance in the 
saphenous system of the rat by performing chronic partial clipping of the main branch. 
In vivo hemodynamical, in vitro biomechanical and quantitative histological testings 
were undertaken.   
 Experiments were performed on male Sprague–Dawley rats weighing 273±40 
(mean±SD) g at the beginning of the experiments. All rats were anesthetized as 
described above. During a microsurgical operation, the most proximal segment of the 
main branch of the saphenous vein was dissected at a distance of 10mm from its 
confluence with the deep femoral vein. A longitudinally slit 4mm long semi-rigid, 
thick-walled piece of a plastic tube with a lumen diameter of 500 µm was placed around 
the vein (Figure 14.). This did not close the vessel but prevented any further increase in 





Chronic partial clipping of the saphenous vein main branch, inducing a flow-pressure. 






Following the induction of AngII hypertension and the partial cclusion of the saphenous 
vein, a series of testing was undertaken.  Pressre-angiometry was performed for all 
dissected segment (both coronaries and venous segments), and for venous segments 
videomicroscopy, hemodynamic measurements, Batson 17 casting, and histologisal 
examination were performed also (Figure 15. and 16.). 
Sex differences in the coronaries in chronic AngII induced hypertension
Sex differences in the coronaries in chronic AngII induced hypertension –
the role of sex hormones





Ovariectomy and estrogen treatment
11 females
Pressure-angiometry following 4 weeks of chronic AngII infucion 
via subcutaneous minipump 
Protocol
Pressure-angiometry following 4 weeks of chronic AngII infucion 
via subcutaneous minipump 
2mmHg - 30 mmHg - 50 mmHg - 70mmHg - 90 mmHg 
pressure increments
1. nKR solution 2. U46619, a TxA2 receptor agonist 3.BK 4. Ca
2+-free Krebs solution.
Protocol
2mmHg - 30 mmHg - 50 mmHg - 70mmHg - 90 mmHg 
pressure increments




This Figure depicts the pressure angiometry protocols performed for all animals that 
had undergone subcutaneous implantation of a minipump to induce hypertension via 




Chronic partial occlusion of the saphenous vein
Videomicroscopy/Hemodynamic measurements








2mmHg - 5 mmHg - 10 mmHg - 15mmHg - 20 mmHg 
pressure increments







This figure shows the test performed on vensous segments. 
  
 
IV/3. In vitro pressure-angiometry 
 
In Vitro Mechanical and Pharmacological Reactivity of the Intramural Coronary Artery 
  After 4 weeks of treatment, all specimens that were implanted with an osmotic 
minipump (male vs female groups and control hypertensive vs. ovariectomy vs. 
estrogen groups) that released Angiotensin II were re-anesthetized as described above. 
Blood pressure was measured directly by cannulating the carotid artery. The heart was 
removed through the chest and placed into cold, oxygenized, normal Krebs-Ringer 
(nKR) solution. The 200 µm secondary branches of the left anterior descending 
coronary artery were isolated, as previously reported byour research group (Mátrai et 
al., 2010; Nádasy et al., 2001; Várbíró et al., 2006). Aftre the segment was mounted in a 
tissue bath as described above both cannulas were connected to pressure-servo systems 
(Living Systems, Burlington, Vermont, US), and the arteries were pressurized under no-





  The outer diameter of the arteries was measured by microangiometry. A 
magnified picture of the vessel was taken with a Philips LDH 0702/20 video camera 
and a monitor (Philips Computer Monitor 80; both Royal Philips Electronics, 
Amsterdam, Netherlands). Two light markers connected to a microcomputer were used 
to measure the inner and outer diameter of the vessel segment (Figure 17.). Diameter 




Images from the monitor of the pressure-angiometry set-up. Light markers are used to 
measure inner and outer diameters of the vessels. 
 
 The intraluminal pressure was measured at both sides of the segments with a 
Gould pressure transducer. The pressure and diameter signals were digitized by an 
analog/digital converter (PCL 7/8, Advantech Corporation, Milpitas, California) and 
transmitted to an IBM Pentium PC computer (IBM, Armonk, New York) for data 
storage and further processing. 
  
Materials for coronary artery studies 
 The composition of the normal Krebs-Ringer solution (nKR) used in these in 
vitro studies was (in millimoles per liter) sodium chloride (NaCL) 119, potassium 
chloride (KCl) 4.7, sodium phosphate (NaH2PO4) 1.2, magnesium sulfate (MgSO4) 
1.17, sodium bicarbonate (NaHCO3) 24, calcium chloride (CaCl2) 2.5, glucose 5.5, and 
EDTA 0.034. The calcium (Ca
2+
)-free Krebs solution contained (in millimoles per liter) 




ethylene glycol tetraacetic acid 2, and EDTA (Ethylenediaminetetraacetic acid) 0.025. 
The temperature of the solution was maintained at 37°C, and it was bubbled with 5% 
carbon dioxide, 20% oxygen, and 74% nitrogen, which stabilized the pH at 7.4.  
 U46619 was used as vasoconstrictor agent.  Alternative Name: 9,11-Dideoxy-
9alpha,11alpha-methanoepoxy prostaglandin Chemical Name: (5Z)-7-[(1R,4S,5S,6R)-
6-[(1E,3S)-3-Hydroxy-1-octenyl]-2-oxabicyclo[2.2.1]hept-5-yl]-5-heptenoic acid 
Biological Activity. U46619 is a PGH2 (TxA2) analog, wich stimulates TP receptor-
mediated, but not other prostaglandin receptor-mediated responses. U46619 has been 
described to be a selective TxA2-mimetic, and is a useful substance it studying the 
effects of TxA2 (Coleman, Humphrey, Kennedy, Levy, & Lumley, 1981). 
 U46619, a thromboxane A2 (TxA2) receptor agonist, and bradykinin (BK) were 
obtained from Sigma-Aldrich Co. The drugs were freshly prepared in nKR solution on 
the day of the experiments. 
  
Angiometry protocol for coronary arterioles - sex differences male vs. female groups 
and ovariectomy vs. estrogen replacement vs. control hypertensive groups 
 
 The coronary arteries were allowed to equilibrate for 30 minutes at 50mmHg 
intraluminal pressure in nKR solution. After this incubation, the pressure was decreased 
to 2mmHg, and then increased first to 30 mmHg, then up to 90 mmHg in 20 mmHg in 
increments. The steady-state diameter was measured at each step. The pressure load 
cycle was repeated with U46619, a TxA2 receptor agonist (at a concentration of 10
–6
 
M), and then with BK (at a concentration of 10
–6
M), both administered into the 
superfusion saline solution with continuous flow, separately, one after another, allowing 
10 minutes of incubation with each drug. Finally, the passive diameter was obtained in 
Ca
2+
-free Krebs solution. The segments were incubated for 20 minutes, and then the 
intraluminal pressure was increased in the previously described increments; the passive 
diameter of the arteries was obtained at each pressure level. 
  
Venous segment protocols 
 In vitro biomechanical testing of the main branch was performed as follows.  




excised (12+8 rats, with four and eight weeks after chronic occlusion, respectively), 
both from the strictured and from the contralateral, non-strictured (control) sides. The 
length of the removed (dissected) cylindrical segments varied between 8 and 12 mm. 
The identical segments of the contralateral side served as controls. The cylindrical 
venous segments were mounted on 500 µm diameter glass cannulas, immersed in 
thermostated saline and stretched to their in vivo length in the glass-bottomed tissue 
bath of the pressure angiometry setup. 
  
Protocol of in vitro angiometry of venous segments 
 The normal-Krebs Ringer (nKR) solution was bubbled with a gas mixture of 
95% oxygen and 5% carbon dioxide. After a 30-min incubation period in nKR solution 
at 5 mmHg intraluminal pressure, pressure was increased in a stepwise manner, to 2-5-
10-15-20 mmHg. Then at 5mmHg intraluminal pressure, 10 µmol/l norepinephrine was 
added to the tissue bath and the measurement cycle was repeated to test contractility of 
the segments. With the norepinephrine still in the bath, 5.5 µmol/l acetylcholine was 
added to study endothelial dilation. Experiments were terminated by recording the 
characteristic pressure-diameter curves in Ca
2+




  IV./4. Intravital videomicroscopy and hemodynamic measurements 
 Intravital videomicroscopy was performed to demonstrate the newly developed 
bypassing collaterals following partial clipping of the saphenous vein in the high-
pressure low-flow venous model. After four and eight weeks, the animals were 
reanesthetized as described above. In vivo videomicroscopic studies of the 
microsurgically dissected specimens were performed on six rats (n=6) (Figure 18.) to 
visualize the morphology of the collateral venous network. To test the effects of chronic 
partial occlusion on the hemodynamics, in separate sets of rats (n=12) venous pressure 
was measured in anesthetized animals through a microcannula (around 200 µm outer 
diameter) introduced into the saphenous vein main branch, distal to the level of the 
stricture, through a popliteal side branch. It was attached to a Braun pressure head and a 




injected into the vein and venous flow was determined by following the movement of 
the stained bolus on a long stretch of the saphenous vein by serial pictures (1 frame/s) 





Intravital videomiscroscopy of the venous segment. The stained bolus, used to determine 
flow is demonstrated. 
 
IV/.5. Histology and immune-histology of the main branch following chronic 
partial clipping of the saphenous branch in high-pressure low-flow venous model 
 In a separate series, the same segments and surrounding tissue were removed for 
histological studies after four and eight weeks of clipping (n=13), and analog specimens 
from contralateral sites served as controls.  Histological samples were stained with 
hematoxylineosin (nuclei) and resorchin-fuchsin (elastica) and immune-histological 
staining was performed for CD68 (macrophage invasion), Ki67 (cellular division 
activity), and smooth muscle actin (SMA, contractile protein).The source of the 
antibodies was the R&D Systems Inc. Secondary antibodies were visualized with the 
DAB technique. The Ventana Benchmark XT Immune-Automat System was used for 
the immunehistochemical staining. This ensured identical staining procedures and made 
the sections comparable with each other. For embedding the specimens tissue array 
technique was used. Sections were scanned with the 3D Histech Pannoramic 250 
Scanner, and selected high magnification (pixel sizes 0.31 µm) RGB pictures (0–255 
levels) were analyzed with the Leica QWin image analysis software. The green (for RF) 
and blue (DAB) levels were measured in a radial line using the ‘‘Measure profile’’ 




(Figure 19.). The colors (green for RF and blue for DAB with methylene blue 
background) were chosen after careful preliminary evaluation of color histograms.  
Distribution of the green color on RF stained sections was measured radially from the 
endothelial surface toward the adventitia. Earlier color analysis histograms were 
showing that green color is suppressed by the magenta color of this dye: more dense 
elastic tissue will be marked by lower green levels. Similar measurements were made 
for smooth muscle actin immunohistochemistry densities (DAB) in blue color. 
 
Figure 19. 
Reorganization of the elastic membrane was quantitatively demonstrated by the green 
color density measurements made in the radial direction outwardly from the luminal 
surface (the magenta color of the resorcin-fuchsin stain suppresses the green 
component).  
  
IV./6. Batson 17 plastic casts 
 Batson 17 plastic casts were prepared in the high-pressure low flow venous 
chronic partial clipping model, to visualize the newly developed collateral network of 
the saphenous vein through a popliteal side branch vein. In Nembutal anesthesia, it was 
possible to fill that collateral system from the direction of the saphenous vein main 
branch using the Batson #17 Anatomical Corrosion Kit. It is used for ambient 
temperature preparation of exact anatomical corrosion specimens by injection of liquid 
plastic. After hardening, the tissue is corroded away by caustic 10% potassium 









Batson 17 plastic cast revealing the newly developed rich collateral system of the 
saphenous vein on the clipped side. 
 
 This procedure is used to produce scientifically exact, multi-colored specimens 
for anatomical study, comparative demonstrations and for quantitative scanning electron 
microscopy studies. It is based on a procedure originated by Professor Oscar Batson of 
the Department of Anatomy at the University of Pennsylvania. The kit consists of 
partially polymerized monomer, a catalyst, and a promoter to allow curing at room 
temperature after injection, and pigments are supplied. Batson 17 plastic cast solution 
for injection was prepared according to specifications for injection and curing, and all 
materials were stored according to manufacturer specifications. Soft tissues were 






IV/7. Biomechanical calculations for all vessel segments 
 From the original calibrated pressure-diameter plots, the following geometric 
and biomechanical parameters were computed for each intraluminal pressure level. The 
tangential stress was computed according to the Laplace equation, σ=P x ri/h   where 
σ is the tangential (circumferential) wall stress, P is the intraluminal pressure, ri is the 
inner radius, and h is the wall thickness (h= ro – ri, where ro is the outer radius). The 
incremental distensibility was Dinc=ΔV⁄VΔP, where Dinc is the incremental distensibility 
and ΔV is the change in vessel lumen volume relative to the initial volume of V in 
response to a pressure change of ΔP. 
  The circumferential incremental elastic modulus was computed from the 






), where Einc is the incremental elastic modulus, 
ri is the inner radius, ro is the outer radius, and Δro is the change in the outer radius in 
response to an intraluminal pressure change of Δp.  
 The spontaneous tone of the vessels was expressed as active strain, quantified 
for each intraluminal pressure level: TnKR=(riCa
2+
-free rinKR) ⁄ ri Ca
2+
-free, where ri 
Ca
2+
-free and ri nKR are the inner radii measured in Ca
2+
-free Krebs solution and in 
nKR solution, respectively. The TxA2-induced tone and BK-induced tone in nKR 
solution was also expressed as active strain, quantified for each intraluminal pressure 
level as follows: TBK=(riCa
2+




-free and ri BK are 
the inner radii measured in calcium-free Krebs solution and BK, respectively. In active 
strain parameters the size of the vascular lumen does not influence the value (%) of 
vascular reactivity. BK-induced relaxation compared with tone in nKR solution was 
calculated with the following formula: BK relaxation=(ri BK - ri nKR)/ri nKR. 
    
Statistical analysis 
 For statistical analysis, the data measurements were compared by 2-way 
ANOVA. The in vitro parameters, plotted as a function of intraluminal pressure 
between groups, were compared by 2-way ANOVA. Paired comparisons for treatment 
groups were made for the curves. As a post hoc test, Tukey‘s test was used. t Tests were 
applied for discrete parameters (e.g., body weights). Paired data were compared with 
paired t-tests.  A P value 0.05 was uniformly accepted as a significant difference. The 






V./1. Sex differences in the remodeling of rat coronary resistance arteries in 
angiotensin II hypertension  
 
Main Biological Parameters 
Following Angiotensin II treatment mean arterial pressure did not differ significantly 
between females (131±5 mmHg) and males (134±7 mmHg) (Table 3.). The heart weight 
index  - meaning the relative weight of the heart, calculated per 100 g body mass - was 
greater in hypertensive females than in males (P<0.001; Table 3.).  
 
Table 3.   
After 4 weeks of AngII treatment, no difference was found in blood pressure between the 
male and female hypertensive groups.  The relative heart weight of the hypertensive 
females was greater compared with hypertensive males. Two-way ANOVA tests between 
the groups are shown, ***P< 0.001. 
 
 
 In the passive state no significant difference was found between the outer radii 
of males and females (measured inCa
2+
free solution) (Figure 20.a). In hypertensive 
females, we observed significantly smaller inner radii (Figure 20.b) and greater wall 
thickness (Figure 20.c) than in males (P 0.05). The difference in cross-sectional areas 
(meaning the overall amount of wall material) did not reach the level of statistical 












Blood pressure, mmHg 131±5 134 ±7 
Heart weight, g/100 g 
body mass 




   





Figure 20.  
Geometric properties of the intramural coronary resistance arteries from male (n=10) 
and female (n=10) rats following 4 weeks of AngII treatment. (a) The values of the 
outer radius as a function of intraluminal pressure measured in the passive condition 
(in calcium [Ca
2+
]-free Krebs solution) male vs. female following 4 weeks of AngII 
treatment. (b) The values of the inner radius as a function of intraluminal pressure 
measured in the passive condition (in Ca
2+-




following 4 weeks of AngII treatment. (c) The values of the wall thickness as a function 
of intraluminal pressure measured in the passive condition (in Ca
2+
-free Krebs 
solution) male vs. female following 4 weeks of AngII treatment.  
 Data are expressed as the means (SEM) values. The significance levels of 2-way 
ANOVA tests between the 2 groups are shown (factors: sex, intraluminal pressure). 
*P<0.05.  
 
Sex Differences in Vessel Biomechanics 
   
 
 
Figure 21.  
The biomechanics of coronary arteries from male (n=10) and female (n=10) rats 
following 4 weeks of angiotensin II treatment. The tangential wall stress of rat 
intramural coronary resistance arteries (male vs. female) as a function of intraluminal 
pressure in the passive condition (in calcium [Ca
2+
]-free Krebs solution) following 
AngII treatment. Data are expressed as means±SEM values. The significance levels of 
2-way ANOVA tests between the 2 groups are shown *P< 0.05.  
 
 Tangential wall stress values, wich shows the mechanical loading of the vessel 







V./2. Remodeling of rat coronary resistance arteries in angiotensin II hypertension.  
Effects of  ovariectomy and  ovariectomy combined with estrogen replacement 
 
Mean arterial pressure 
The mean arterial pressure of the control hypertensive group was 130±5 mmHg, the 
ovariectomized hypertensives had pressures of 134±6 mmHg, and the ones given 




The following table shows the summary of biomechanical parameters calculated for the 
AngII, AngII+ovariectomy, AngII+ovariectomy +estrogen therapy (Table 4.). 
 
Table 4. Biomechanical parameters for the following three groups are shown:  
Angiotensin II; Angiotensin II treatment + ovariectomy [OVX]; Angiotensin II + 
ovariectomy [OVX]+ estrogen therapy). Parameters were calculated for the three 
groups at intraluminal pressure of 50 mmHg as this correlates with in vivo transmural 
pressure. Relative heart weights were normalized for 100 g of body weight. 
 
 
 No difference was found in terms of wall stress, distensibility (Table 4.), and 
elastic moduli among the three groups (“control” Angiotensin II; Angiotensin 
II+ovariectomy [OVX]; Angiotensin II+ovariectomy [OVX]+ estrogen therapy) (Table 
4.).The cross-sectional areas and wall to lumen ratios of vessel wall did not differ 
among the three groups (Table 4.). 
 Vessel geometry of intramural coronary arterioles was analyzed following 




female rats. Ovariectomy reduced the lumen from 270±14µm to 254±14µm, while 
estrogen treatment  not only restored lumen diameter but resulted in even higher values 
than in control AngII treated rats 284±24 µm. (Ovariectomized significantly smaller 
than not ovariectomized or ovariectomized plus estradiol replaced, p<0.05).  
 We found similar results regarding the outer radius (Figure 22.a). However the 
differences between the groups regarding wall thickness did not reach the level of 





Figure 22.  
(a)Outer radius values from the control angiotensin II-treated group (AngII; full 
circles, n=11), angiotensin II treated plus ovariectomized group (OVX; empty circles, 
n=11), and angiotensin II treated, ovariectomized and estrogen –replaced (full 




of statistical difference between the groups. Mean ±SEM values. Asterisk indicates 
statistical significance (P<0.05) between ovaryectomized groups with 
nonovariectomyzed and ovariectomized plus estrogen replaced groups.  
 
Effects of ovariectomy, and ovariectomy plus estrogen therapy on the contractility of  
hypertensive intramural coronary arterioles 
In our series spontaneous myogenic tone was higher in the estrogen treated group 
compared with the ovariectomized group (Figure 23.a) There was no difference in 
U46619-induced tone between the groups (Figure 23.b). 
(a) 
(b) 
Figure 23.  
(a) Myogenic (spontaneous) tone, (b) TxA2-induced tone of rat intramural coronary 
arterioles as a function of intraluminal pressure; values from the control angiotensin II-
treated group (AngII; full circles, n=11),  angiotensin II treated plus ovariectomized 




estrogen-replaced (full triangles,n=11) animals. Mean ±SEM values. Asterisk indicates 
statistical significance (P<0.05) between control AngII and estrogen-treated groups 
versus OVX group. Spontaneous myogenic tone was higher in the estrogen-treated 
ovariectomized group compared with the ovariectomized group without hormone 
replacement. There was no statistically significant difference in U46619-induced tone 
between the groups. 
  
 Following application of bradykinin to the tissue bath remaining tone was 
significantly higher both in non-ovariectomized and in the estrogen-treated 
ovariectomized groups compared with the ovariectomized animals without estrogen 
hormone replacement. Estrogen+Ovariectomy+AngII, 11.1 ±2.1%, AngII 9.9±2.8%, 
and Ovariectomy+AngII 6.6±2.0% at P=50 mmHg in BK-induced relaxation. 
Comparing with spontaneous tone, there was no significant relaxation in the 
Ovariectomy+AngII and the AngII group; however, estradiol treatment restored nitric 









Figure 24.  
Bradykinin (BK)-induced tone of the rat intramural coronary arterioles was expressed 
as active strain and a function of intraluminal pressure (10
-6
M BK). Values from the 
control angiotensin II-treated group (AngII; full circles, n=11), ovariectomy (OVX; 
empty circles, n=11), and estrogen-treated (E; full triangles, n=11) groups are shown. 
Mean SEM values. Asterisk indicates statistical significance (P<0.05) between 
estrogen-treated group versus OVX group in respect of BK-induced tone (a) and control 
AngII and estrogen-treated groups versus OVX group in respect of BK relaxation (b). 
Remaining tone was significantly higher in the estrogen-treated and control AngII 
hypertensive group compared with the ovariectomized animals in BK-induced 
relaxation. Comparing with spontaneous tone, there was no significant relaxation in the 
ovariectomized group; however, estradiol treatment restored nitric oxide-dependent, 
BK-induced relaxation to the hypertensive control level. 
 
V./3. The effects of high-pressure low-flow conditions induced by chronic stricture 
of the main branch of the saphenous vein   on the hemodynamics of the saphenous 
main branch. Biomechanical alterations of the main branch following partial 
clipping of the main branch of the saphenous vein 
  
The effects of high-pressure low-flow conditions induced by chronic stricture of the 
main branch of the saphenous vein  saphena on the hemodynamics of the saphenous 
main branch 
 In accordance with our expectation chronic partial occlusion of the saphenous 
vein induced a substantial pressure rise was observed in the main branch.  
Measurements were taken in anesthetized animals in the supine body position and we 
found that in comparison to the control side venous pressure doubled, p<0.001 with 
two-way ANOVA (Figure 25.a) 
 The rise in pressure was accompanied by a drastic drop in the flow values of the 
main branch. After eight weeks of occlusion, control side flow of 3.5±1.4 µl/s dropped 
to a mere 0.65±0.18 µl/s at the side of the stricture, p<0.001 with two-way ANOVA 
(Figure 25.b). Reduction of blood flow seems to be induced by diversion of blood from 








Figure 25.  
Main branch of the saphenous vein was narrowed to 500µm for 4-8-12 weeks, 
contralateral saphenous veins served as controls. Black circle clipped side, empty circle 
– control side. (a) Saphenous vein pressure plotted against weeks of occlusion. Venous 
pressure doubled compared to control side. (b) Saphenous vein flow plotted against 
weeks of occlusion. At eight weeks of occlusion, control side flow of 3.5±1.4 µl/s 
dropped to 0.65±0.18 µl/s on the clipped side. ***p<0.001, significant difference 
between marked groups, according to one- and two-way ANOVA tests 
 
Biomechanical alterations of the main branch following partial clipping of the main 
branch of the saphenous vein. 
  A reduction in diameter of the clipped segments in comparison with their 




pressure of 10mmHg, the relaxed outer diameter of clipped segments reduced to 642±29 
µm in comparison with 764±24 µm of the control side (p<0.001 with the paired t-test). 
Corresponding values following eight weeks of clipping were 613±30 µm and 734±25 




Figure 26.  
Hemodynamically induced biomechanical remodeling of the saphenous vein main 
branch. Relaxed diameter clipped and control saphenous vein segments following 4 
weeks and 8 weeks of clipping plotted against pressure in calcium-free medium. 
 
 Following eight weeks of clipping, the wall thickness values of the clipped 
segments were significantly reduced compared to those found in the contralateral side 










Figure 27.   
Hemodynamically induced biomechanical remodeling of the saphenous vein main 
branch. Cross section areas (a) and wall thickness (b) of clipped and control saphenous 





 Low-stress elastic modulus decreased between weeks 4 and 8 in controls 
however this reduction was less on the clipped side. When elastic moduli were plotted 
against wall stress, after four weeks, the low stress modulus increased and the high 
stress modulus decreased in obliterated segments (Figure 28.). Their values were at 0.5 
kPa wall stress 4.36±0.30 vs. 3.65±0.22 and at 1.5 kPa wall stress 4.58±0.15 vs. 
4.88±0.20, for clipped and control sides, respectively (logarithmic values in lgPa, 







Figure 28.  
Hemodynamically induced biomechanical remodeling of the saphenous vein main 
branch. Log elastic modulus plotted against intraluminal pressure of clipped and 
control saphenous vein segments following 4 weeks and 8 weeks of clipping. 
 
Alterations in contractility of the main branch following partial clipping of the main 
branch of the saphenous vein. 
 We found that the induced low flow–high pressure remodeling massively 
reduced contractility. Spontaneous tone was found to increase between weeks 4 and 8 in 
control segments (p<0.01), however this increase was missing in the clipped side. As a 
result, after eight weeks, clipped segments exhibited much smaller spontaneous tone 
than control ones (Figure 29.a)(p<0.01). Similar observations were found regarding 
maximal contraction induced by norepinephrine (Figure 29.b). After four weeks of 
partial occlusion the reduction in contractility reached the level of statistical 
significance (p<0.05). In addition, reduced endothelial dilation capacity was found in 









Hemodynamically induced biomechanical remodeling of the saphenous vein main 
branch. Clipped and control saphenous vein segments were analyzed following 4 weeks 
and 8 weeks of clipping. (a) Spontaneous tone as a function of pressure. (b) 
Norepinephrine-induced tone (10 µM/l) as a function of pressure. (c) Ach-induced 
(endothelial) dilation as a function of pressure. *p<0.05, **p<0.01, ***p<0.001, 










V./4. The effects of high-pressure low-flow conditions induced by chronic stricture 
of the main branch of the saphenous vein  saphena  on the collateral system of the 
saphenous main branch 
  
Geometry of the venous networtk following 4 and 8 weeks of  partial obstruction of the 
saphenous vein 
 When incising the inguinal skin of the reanesthetized animals, a rich bypassing 
collateral system was found on the clipped side under video-microscopic examination. 
Brush-like conglomerates, consisting of several hundred small veins, running mostly 
parallel, were observed, and they were leading away from the affected main branch 
(Figure 30.a). Some of these branches bypassed the artificial stricture, and some of them 
dilated forming corrugated collaterals. We could prove that blood flow was leading 
away from the main branch via these newly developed veins by analyzing the direction 
of flow as they filled up and by the serial pictures made after injecting either methylene 
blue or saline into one of the popliteal side-branches of the saphenous vein. The 
collateral system could be filled from the direction of the saphenous vein main branch 
using Batson 17 plastic in a retrograde manner. On the contralateral unclipped veins, 
such retrograde filling side-branches were scarcely observed, and existing valves in the 
vicinity of the confluence effectively closed retrograde flow. Cross sections of such 
multiple bypassing side-branches could also be observed on the histological sections 
(30.b). 
 
Figure 30. (a) 
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Figure 30.b  
Histological samples 
1. Network and wall (smooth muscle) remodeling. Note intensive smooth muscle actin 
(SMA,DAB, arrows) staining marking developed small collateral veins.  
2. Network and wall (elastica) remodeling Resorcin-fuchsin staining. Note fragmented 
inner elastic membrane in main branch (black arrow) and weak staining in newly 
developed smaller collateral veins in the surrounding tissue red arrows).  
3. Ki67 (cell division activity) in tissue area with intensive collateral vein neoformation. 








V./5. The effects of high-pressure low-flow conditions induced by chronic stricture 
of the main branch of the saphenous vein   on the histological characteristicsof the 
saphenous main branch 
Inflammation, New cell formation   
 Histological analysis, CD68 staining proved the presence of macrophage 
invasion (Figure 31.a). With Ki67 stining there was evidence of new cell formation and 
at the occlusion site (Figure 31.b). The presence of a few (usually one or two) cells with 
cell division activity can be considered a normal feature – based on findings from the 
control side (Figure 31.c).  
 
 
Figure 31.  
Histological wall remodeling following four weeks of partial occlusion of the saphenous 
main branch. Immuno-histochemical staining. Arrows show positively staining 
structures. Bars, 50 µm. (a) CD68 (macrophage activity), clipped side; (b) CD68 
control side. Macrophage activity was found to be much higher on the clipped sine. (c) 
Ki67 (cell division activity), clipped side; (d) Ki67, control side. Ki67 staining revealed 






 Resorchin-fuchsin (RF) staining was performed to track alteration in the elastic 
component of the vessel wall revealed a massive remodeling of the elastic components 
in the wall. Quantitative image analysis was performed and we found that the inner 
elastic membrane became less condensed, and less organized in the clipped, remodeled 




Figure 32.  
Remodeling of the elastic components after four and eight weeks of partial occlusion of 
the saphenous vein. (a to e) Resorcin-fuchsine-stained (RF) sections. (a) Four weeks 
occlusion clipped side; (b) four weeks control side; (c) eight weeks clipped side; (d) 
eight weeks control side. Bar, 50 mm (valid for a–d). Organized, condensed elastin 
became less condensed and fragmented on the occluded side.  
 
 Green density measurements did not show as low values in the vicinity of the 
endothelium of clipped side venous segments than in their unaffected contralateral 
controls (Figure 33.)(p<0.01). This demonstrates a reduced compactness the inner 




remodeling of the morphological lumen, the original inner elastic membrane should be 







Remodeling of the elastic components after four and eight weeks of partial occlusion of 
the saphenous vein. (a) Results of RF elastica density measurements in the green color 
as a function of distance from the luminal surface. Lower green values represent higher 
elastica density. Each curve represents 5–8 rats, and 15–24 measurements were made 
on each venous segment. (b) Minimum values of the above density curves showing 
maximum inner elastic membrane densities. Color code identical with that of (a).  
 
 Another observation is that peripheral elastic elements diminish between four 
and eight weeks in controls. This process seems to be less effective in clipped segments 




different (p<0.01) not only around their minimums, but in a distance of 0.3–10 µm (four 
weeks) and 3–17 µm (eight weeks) measured radially outward from the endothelial 
surface (on formaldehyde-fixed segments). The significance of elastic remodeling is 
outlined by tha fact that comparison of RF densities with measured elastic parameters 
revealed a close to linear function between elastic densities in the range of 10–15 µm 
from luminal surface and elastic modulus measured in spontaneous tone at 10 mmHg 




Figure 34.  
Remodeling of the elastic components after four and eight weeks of partial occlusion of 
the saphenous vein. (a and b) Elastic moduli are plotted against RF green density in the 
range of 10–15 µm from the luminal surface. (a) Moduli of segments in the spontaneous 
tone at physiologically feasible higher pressure (10 mmHg). (b) Passive moduli at low 
pressures (2 mmHg). Statistical differences with one- and two-way ANOVAs are shown, 
**p<0.01 between clipped and controls at four weeks, 
##
p<0.01 between clipped and 
controls at eight weeks. 
††





 The applied low flow–high pressure hemodynamic challenge also induced a 
remodeling of the contractile elements: age-induced accumulation of the contractile 





Figure 35.  
a-d Remodeling of the contractile components after four and eight weeks of partial 
occlusion of the saphenous vein. Smooth muscle actin (SMA-DAB) immune-
histochemistry. (a) Four weeks’ occlusion; (b) four weeks’ control; (c) eight weeks’ 
occlusion; (d) eight weeks’ control. We found that accumulation of the contractile 
proteins in the inner layers of the tunica media was less effective in clipped segments 
Bar, 50 mm (valid for a–d).  
At the same time, both at week 4 and 8, there is more contractile protein present 
scattered in the outer layers of the media in the occluded segments. (Figure 37)( p<0.01 
with two-way ANOVA). The explanation seems to be that during morphological 
remodeling of the wall the area of contractile protein accumulation was less focused 








Density measured in blue color as a function of distance from the endothelial surface. 
At 4 and 8 weeks of occlusion, we found more contractile protein present scattered in 
the outer layers of the media in the occluded segments. **p<0.01 between clipped and 
controls at four weeks, 
##






 Adaptive mechanism of the vasculature - which is a complex complex and 
highly versatile system – may be promted by many factors. Adaptation may take the 
form of biomechanical remodeling may occur as a consequence hemodynamic, 
endocrine and others factors. Remodeling machanisms vary depending on the specific 
segment, the hemodynamic feature altered altered (pressure/flow), and the endocrine 
enviroment, i.e. sex hormones.  
 Remodeling occurs along the vasculature in several diseases that have a large 
adverse impact on the well-being of the population. Coronary pathologies in 
hypertension affects the population in high numbers. A study of men and women aged 
45 to 83 years showed the age-standardized prevalence of hypertension at baseline was 
74.3% for men and 70.2% for women (Lacruz et al., 2015). Understanding the 
mechanisms through which coronaries adapt to hypertension is key in the possibility to 
impede deliterious effects of hypertension. Hypertension is a common pathological state 
in postmenopausal women; the geometrical, contractile, and mechanical properties of 
intraluminal coronary resistance arteries play a paramount role in hypertensive and 
ischemic heart disease. Judging from the statistics that show a definite difference in the 
degree to wich men and women are effected by coronary heart disease, it is sensible to 
suspect therole of sex hormones in the adaptation mechanisms of coronary arteries. As 
women are less effected my coronary heart disease the effects of female hormones, or 
lack of female hormones are important to understand in desiging research projects for 
therapy in the future. We have to recall here that intramural coronaries are mainly 
responsible for the blood supply of the heart. Such arteries are extremely difficult to 
examine in humans, therefore an animal model is paramount.  
 There is increasing evidence to suggest that sex hormones play a very diversified 
role in cardiovascular pathologies, and in turn in coronary remodeling. Limitation of our 
experiments are that estrogen therapy only was investigated, even though other sex 
hormones may play a role in the development or more importantly in the prevention of 
vascular pathologies in hypertension (i.e. progesterone). Another limitation of our 
experiments is that the specific effects of testosterone were not investigated. The strong 




but pathophisiologically cardinal intramural coronaries. It is unique in stripping back to 
the basic biomechanical essence of sex differences and the role of sex hormonesin the 
remodeling of coronaries in hypertension. Through our experiments we may capture 
step-by-step the way the vascular wall adapt to pressure loading.  
 The adaptive mechanisms of the vasculature play a role in the development  of 
another common disorder, varocosities. Varicosities are a widespresd disease, with 
prevalence reaching  56% in males, and 73% in females (Beebe-Dimmer, Pfeifer, Engle, 
& Schottenfeld, 2005; Robertson, Evans, & Fowkes, 2008). The significance of 
pressure load has been emphasized in the literature for a long time, however structural 
changes in the vessel wall, and flow-induced adaptations may also play a role in the 
development of varicosities. One of the strong suit of our experiments is that in 
provided a reliable animal model for the development of a collateral network 
reminiscent of that seen in the early stages of varicose disease. Another advantage is 
that this early stage remodeling prompted by a high-pressure low-flow environment was 
analyzed by a range of techniques (pressure-angiometry, morphological studies, 
histopathology etc.), thereby proviging us with a wide scope of information. 
 It is a well recognized fact that pressure will affect the vasculature both on the 
arterial and venous side. However we found that the remodeling that occurs as a result 
of a chronic rise in pressure differs based on the segment studied (arterial/venous), sex, 
and the hormonal environment provided.  Different segment will demonstare different 
remodeling strategies in the face of pressure loading. Particulars will be discussed 
below.  
 Based on the literature and our experiments inflammation and inflammatory 
proteins are associated with vascular remodeling in both hypertension and varicose 
disease. It is not yet clear whether inflammation instigates, propagates, or accompanies 
vascular remodeling, however it appears, that they are linked. Limitation of our 
experiments is that inflamamtion was studies only in the setting of venous remodeling. 
   Following the structure that was followed in the Intrduction, Aims, Methods 






VI./1. Sex Differences in the Biomechanics of Intramural Coronary Arteries in 
Angiotensin II–Induced Hypertension 
 Chronic AngII treatment raised mean arterial pressure significantly, modeling 
the early stages for AngII-induced hypertension as expected. Adverse vascular changes 
have been demonstrated to follow (Mátrai et al., 2010). 
 In earlier studies we analyzed the potential biomechanical differences between 
intramural coronary resistance arteries of male and female rats and certain differences 
were found i.e. higher wall thickness and higher vascular contractility in males were 
associated with similar endothelial function and larger high-pressure elasticity 
compared to females (Mátrai et al., 2007).  
 In our current study we aim to understand the sex-related biomechanical 
adaptation in hypertension the same coronary segments. In females inward eutrophic 
remodeling and an increase in relative heart mass was found. However in males, we 
found an increase in wall strain with initial morphologic stability of the vessel wall. 
According to the data in the literature these alterations develop only following a longer 
period of hypertension.   
 When comparing the results of these two studies the higher wall thickness we 
found in AngII hypertensive female rats was the opposite of what we found in 
normotensives, in which males had thicker walls and, consequently, lower values of 
isobaric wall stress (Mátrai et al., 2007). There is limited data available on the 
biomechanical adaptation of this coronary segment Park et al (Park et al., 2008) found 
higher arterial elastance in hypertensive females than in males during physical exercise. 
Such differences disappeared when normalized to body surface in their study.  
 Sex chromosomes and therefore certain ganatic differences may also play a role 
in hypertension. Differences in the sympathetic nervous system and the renin -
angiotensin system have been described to be linked to the Y chromosome.  
Angiotensin-converting enzyme inhibitors have also been described to be the most 
effective antihypertensive medications in females (Stimpel, Koch, & Oparil, 1998). We 
may draw hypothesize that in females AngII is the most important hypertensive 
stimulus. The underlying molecular mechanisms are the c-fos and c-jun pathways, 




that the expression of AT1R is decreased as an effect of estradiol (Gragasin, Xu, 
Arenas, Kainth, & Davidge, 2003; Koganti, Snyder, & Thekkumkara, 2012).  
 We found that ovariectomy led to an increase in blood pressure and a decrease in 
endothelium-dependent relaxation in AngII induced hypertension in female rats. The 
underlying causes includee alterations of nitric oxide and the renin-angiotensin system 
(Xu et al., 2008). Castration been shown to normalize increasing blood pressure in male 
rats, and ovariectomy led to increased blood pressure in females (Grigore, Ojeda, & 
Alexander, 2008). These phenomena were described to be mediated by the renin-
angiotensin system, through testosterone (Ojeda et al., 2010). The effects of male sex 
hormones on the vascular system are controversial; it is now believed that testosterone 
dominantly affects the renin angiotensin system and increases sympathetic tone, leading 
to vasoconstriction and the progression of atherosclerosis (Kienitz & Quinkler, 2008). 
 In our current studies was found that wall thickness was greater in females, 
leading to lesser relative mechanical loading. In males the vessel wall was more rigid 
and the vessel wall showed less hypertrophy, which means that the mechanical loading 
was greater. In our series we found that optimizing mechanical loading was the primary 
adaptation mechanism in females, whereas preventing thickening of the wall was most 
important in males. From a biomechanical point of view the essence of this difference 
between the genders was that although hypertrophy of the wall to normalize wall stress 
was more apparent in females than in males, the dominant compensatory mechanism 
was an increase in wall rigidity, which was directly responsible for the blood supply of 
the heart muscle. In spontaneously hypertensive rats, Bonacasa et al (Bonacasa et al., 
2008) observed decreased remodeling of the coronary arteries after methoxyestradiol 
treatment of oophorectomized females and intact males. Pressure load may also affect 
and damage the microvessel network of the heart more directly. This may explain 
certain aspects of the sex differences in the incidence of myocardial infarction as well as 
biomechanical differences found between the coronary arteries of males and females.  
 n our previous studies, as greater contracture could be evoked in normotensive 
males, (Várbiró et al., 2006) whereas no difference was found concerning spontaneous 
myogenic tone between the seyes (Mátrai et al., 2007). Thus hypertensive males 




remodeling (namely vessel wall hypertrophy, which compensates for greater pressure 
loading).  
 We believe that these differences can be attributed to different testosterone and 
estrogen levels (Grigore, Ojeda, & Alexander, 2008). Middle-aged and older men are 
under more pronounced endothelin receptor A vasoconstrictor control than women 
(Stauffer et al., 2010) Ca
2+
 current density was higher in whole cell clamps of vascular 
smooth muscle cells prepared from the coronary arteries of male miniature swine 
compared with those from female swine (Bowles, 2001). 
 In accordance with our findings isolated vascular smooth muscle cells from 
female rats have been shown to respond with less contraction to different stimulus than 
male rats (Ma et al., 2010). Endothelial nitric oxide release and vasodilation have been 
found to be stimulated by estradiol in coronary arteries, including cases of hypertension 
(Levy, Chung, Kroetsch, & Rush, 2009; Orshal & Khalil, 2004). Our studies revealed 
less remaining tone after BK-induced endothelial coronary dilation in long-term AngII–
infused female rats than in males. 
 Short term - 10 days - AngII treatment in males has been shown to lead to 
upregulation of the NAD(P)H oxidase gp 67 phox subunit in the mesenterial vessels, 
resulting in mesenterial vascular dysfunction (Tatchum-Talom, Eyster, & Martin, 2005). 
In hypertension, the G protein coupled receptor kinase had partial effects on-adrenergic 
receptors in males and AngII receptors in females (Keys, Zhou, Harris, Druckman, & 
Eckhart, 2005). 
 In our model of single common etiology hypertension, AngII, age-matched 
animals, cardiac remodeling was observed in females as elevation in heart weight index, 
whereas this phenomenon did not reach the level of statistical difference in males. 
Based on unpublished data from our previous work we did not find gender differences 
in the normotensive state (0.32±0.02 g/100 g body weight in males vs. 0.32±0.02 g/100 
g body weight in females); therefore, this difference in relative heart weight in 
hypertensive animals was caused by altered adaptation mechanisms in hypertension.We 
found that hypertrophic remodeling did not appear in the coronary arteries in femles but 
in cardiac muscle only.  
 The dominance of angiotensin-dependent mechanisms suggested that 




AngII-induced hypertension, we found differences in the contractile reactivity of the 
intramural coronary small arteries. The extent of TxA2-induced vasoconstriction was 
greater in the intramural coronary arteries of males than of females. Different segments 
of the coronary network showed different vasoconstrictor reactivity (Szekeres et al., 
1998). Sex differences in the effects of TxA2 have been described in epicardial coronary 
arteries. Secondary mesenterial arteries showed markedly stronger contractions in 
response to TxA2 agonists than did the main branches (Nobe, Hagiwara, Nezu, & 
Honda, 2006).  
  
  
VI./2. Estrogen therapy may counterbalance eutrophic remodeling of coronary 
arteries and increase bradykinin relaxation in a rat model of menopausal 
hypertension 
  
 It has been postulated however that menopausal hypertension may lead to 
different vascular adaptation mechanisms compared with those observed earlier in 
normotension (Mericli et al., 2004). In our study we focused on sexual steroid-related 
vascular adaptation in hypertension.  
 
Geometry 
 In the early stages of AngII-induced hypertension unwelcome changes in vessel 
geometry, such as a decrease in coronary lumen have been described. In our series even 
though the lumen of the AngII+OVX group was significantly narrower, the cross-
section of vessel wall did not differ compared to AngII only “hypertensive control” 
group. This is in accordance with eutrophic remodeling (Mulvany, 1999).  
 Estrogen has been proven to counterbalance adverse vascular effects of 
ovariectomy in certain regions, such as the hypothalamus (Szelke et al., 2008). An 
important observation of ours is that estrogen therapy leads to an increase in coronary 
vessel lumen despite maintained hypertension. The eutrophic wall remodeling seen in 







 Key alterations were observed in our series regarding coronary contractility. 
Earlier work demonstrated that U46619 constrictions were elevated in the AngII 
hypertensive group compared with controls. Stabilization of this contracted lumen may 
be a possible mechanism responsible for the observed eutrophic remodeling (Mátrai et 
al., 2010).  
 In this series we did not observe a statistically significant difference in U46619-
induced tone between the ovariectomized and hormone therapy groups (Figure 23.b). 
Spontaneous myogenic tone and remaining tone after BK-induced dilation however 
were higher in the control hypertensive and estrogen-treated groups compared with the 
ovariectomized group. This elevated spontaneous tone in vivo may allow for a greater 
functional range, and a greater capacity for vasodilation, and therefore may be 
considered to be a cardioprotective mechanism.  From pathological and clinical point of 
view it is impressive that vasodilation to BK practically disappeared in the ovariectomy 
group, meaning that this key vasodilatative mechanism was practically lost. It is 
important to state, that it was retained in the estrogen therapy group. 
 
Biomechanical parameters 
 In a previous study we found that tangential wall stress and elastic modulus 
decreased significantly in hypertensive animals compared with normal ones, especially 
at high-pressure levels (Mátrai et al., 2007). In the present series however no further 
difference was found in terms of wall stress, distensibility, and elastic moduli between 
ovariectomized and hormone therapy groups. 
  
 
VI./3. Remodeling of the venous wall  in high pressure-low flow conditions 
 Pressure as an etiological factor in the development of varicose veins has been 
discussed in detail in the literature (REFS). Little is known however on the effects of 
chronic altered flow conditions on the venous system of the lower limb. Our 
hemodynamic measurements showed a reduced flow and doubling of venous pressure in 
the strictured main branch (Figure 25. (a-b)). Based on the literature it would have been 




our studies unanimously confirmed that partial occlusion of the main branch of the 
saphenous vein did not lead to the expected varicosity-like pressure induced dilation, 
but instead morphological involution of the wall and of the lumen was observed. There 
was a significant decrease of the passive outer diameter of partially occluded segments 
in comparison to controls at weeks 4 and 8 alike (Figure 26.). We found that wall 
thickness (Figure 27.) and wall mass (Figure 27.) of the control side veins increased 
over the examined period of time however, this did not occur on the partially occluded 
side. The differences between occluded and non-occluded sides were statistically 
significant. Acting chronically the low–flow high pressure hemodynamic environment 
massively altered segmental geometry.  After a combined biomechanical– histological 
study of the main branch, we can conclude that the wall had sufficient strength to 
withhold doubling of luminal pressure without any morphological distension. Our 
results suggest that these alterations are the result of chronic adaptation to reduced flow. 
Venous inflow into the main branch was directed toward the newly developed 
bypassing venous routes with ‘‘inverted flow’’ flow. 
 Such massive changes in wall geometry cannot be expected to occur without 
parallel changes in wall elasticity (Figure 28.) demonstrate that really that is the case. 
As measured by quantitative histochemistry, the structure of the inner elastic membrane 
of the wall of the occluded segments loosened and became less dense (Figure 32.) 
which corresponds with reduced passive elastic modulus at the physiologically relevant 
1.5 kPa level wall stress. Elastic elements outward from the inner elastic membrane 
were also affected. A spontaneous reduction of such elements between weeks 4 and 8 is 
less effective. Our analysis suggests that the presence of fragmented dense elastic 
elements in the outward vicinity of the inner elastic membrane, at a distance of 10–15 
µm from the endothelial surface (Figure 34.), is an important factor determining elastic 
modulus at low pressures in the passive state (Figure 34.) and also at higher pressure 
with some smooth muscle tone. 
 Another important observation of ours was reduced contractility. Both 
spontaneous tone and norepinephrine induced tone decreased (Figure 29.a-b). Actin 
density in the inner medial layers did not differ between clipped and non-clipped sides, 
and this cannot explain the observed significant reduction in the contractile force. The 




wall, however, marks that contractile elements are also affected by the low flow–high 
pressure remodeling process. There is an accumulation of the contractile proteins in the 
inner medial layers between weeks 4 and 8 even in controls with substantial elevation of 
contractile force. This process is less effective in clipped segments, or results in 
accumulation of scattered contractile elements in the outer layers without any 
improvement of contractility. 
  The almost total loss of endothelial dilation capacity after eight weeks of 
clipping (Figure 9.(h)) cannot occur without pathological consequences. According to 
analogies observed on resistance arteries, it can be connected with lowered flow and be 
responsible for lumen shrinkage. Such mechanism may play an essential role in the 
development of the human varicosity disease: venous branches occluded for longer 
periods by sustained isometric muscle contraction can be expected to shrink 
morphologically and also loose their ability to dilate at intermittent release of muscle 
tone. Flow will be diverted to pathologic direction by tsuch mechanisms. 
 
VI./4.Early stage varicose disease 
 The relationship between pressure, flow and chronic venous disease has long 
been investigated (Bergan et al., 2008). Mechanisms such as turbulence shear force, 
(Fegan & Kline, 1972) increased wall tension, (Raffetto & Khalil, 2008) and 
inflammatory cascades have been suggested to lead to changes in vessel wall structure, 
and alteration in constriction/relaxation properties seen in varicose veins. More recently, 
a theory was introduced naming impending venous drainage, and outflow obstruction as 
the underlying cause of the formation of varices (Gaweesh, 2009; Neglén, Thrasher, & 
Raju, 2003).  
 To substantiante the relationship between pressure and the development of 
varicose veins an animal model was developed in our laboratory was based on the 
commonly accepted theory that the formation of varicose veins is mainly driven by 
pressure loading. Rats were submitted to chronic gravitational loading and during the 
course of this study several adaptive and pathological alterations were identified in the 
venous network. However, classic pathological remodeling characteristic for chronic 




dilations, torques or plaques was not observed (Lóránt et al., 2003; Monos et al., 1995; 
Monos et al., 1989; Monos et al., 2007; Raffai et al., 2008).  
 Observations on how vein structure, geometry, elasticity, and contractility are 
affected by varicose disease are divergent. An ultrasound study suggested that varicose 
vein sections may show dilatation of the lumen compared with the control with no 
change in the wall thickness itself. Wall thickness compensation in this case is by 
production of collagen instead of smooth muscle (Wali & Eid, 2001). 
 There is evidence to suggest that the formation of varicose veins may be due to 
the weakness of the vein wall as a result of significant increase in intimal and medial 
thickness and elevation of collagen content in the media with concomitant decrease of 
elastin content (Elsharawy, Naim, Abdelmaguid, & Al-Mulhim, 2007). The reduced 
amount and fragmented state of elastic fibers, (Kirsch et al., 2000) dysregulation of the 
synthesis of collagen I and III in smooth muscle cells, (Sansilvestri-Morel et al., 2001) 
and overexpressed aFGF in the wall via FGFR and the MAP kinase pathway may 
influence expression of enzymes involved in extracellular matrix metabolism (R. 
Kowalewski, Malkowski, Sobolewski, & Gacko, 2009) may also play a role in vein wall 
remodeling, leading to the described rigidity (Kirsch et al., 2000). 
  It has been suggested that smooth muscle cells derived from varicose veins are 
less differentiated and demonstrate increased proliferative and synthetic capacity than 
those derived from normal veins and may therefore contribute to the weakening 









Conclusions regarding differences between the sexes in terms of vascular remodeling in 
the coronary resistance arteries of the rat following angiotensin II induced hypertension 
 The early steps of angiotensin II–dependent hypertension evoked very different 
adaptation mechanisms in males and females. Vessel wall remodeling and an increase in 
relative heart weight in females was seen. Increased mechanical loading prevented 
remodeling in this stage in males.  
 
Conclusions regarding the effects of ovariectomy and hormone replacement on the 
remodeling of intramural coronaries, which play a cardinal role in cardiovascular 
pathophysiology 
 Estrogen therapy has an opposite effect on vascular lumen as ovariectomy and 
AngII treatment, which produces eutrophic remodeling. Estrogen may therefore be 
considered to counterbalance the adverse changes seen in the vascular wall of 
intraluminal coronaries in the early stages of chronic hypertension. In the absence of 
estrogen NO-mediated dilation becomes vulnerable in the face of early chronic 
hypertension, opening the gate to further remodeling and vascular damage. Estradiol 
therapy leads to an elevation of spontaneous tone, allowing for greater range for 
vasomotion, meaning a greater capacity for dilation.  
 
Conclusions regarding the effects of an increase in venous pressure and decrease of 
venous flow on the geometrical and biomechanical characteristics of the saphenous vein 
main branch in chronic main branch stricture model in rats  
 Involution of the wall and lumen was observed. Blood flow decreased and 
pressure elevated under high pressure low-flow conditions in the saphenous vein model. 
Contrary to expectations, the main branch did not dilate morphologically, instead 
involution with morphologically reduced lumen, reduced wall thickness and reduced 




shrinking of the lumen in veins may override pressure-induced morphological 
distension.  
 
Conclusions regarding evidence of collateral network formation following partial 
clipping of the main branch of the saphenous vein of the rat  
 The high-pressure low-flow environment created by partiel occlusion of the 
saphenous vein led to the development of a rich bypassing collateral network on the 
clipped side, morphologically reminiscent of early stage varicose disease, with brush-
like conglomerates.  
  
Conclusions regarding evidence of macrophage invasion and new cell formation at the 
clipping site in chronic main branch stricture model in rats 
 As a result of low-flow induced remodeling (i.e-morphological shrinkage) may 
override the passive distention induced by chronically elevated venous pressures. 
Loosening of the force-bearing elements during flow-induced wall remodeling may be 
an important pathological component in varicosity. Elastic modulus is dependent on the 
presence and amount of fragmented elastic elements in the media, but outward from the 
inner elastic membrane. The scattering of contractile elements leads to a substantial loss 
of contractile force. 
 In case of both elastic and contractile elements, not only the amount of tissue, 
but also their distribution in the different layers of the media has a decisive mechanical 
role. Such observations, we believe, should be taken into consideration when explaining 






    VIII. Summary 
  
 The aim of this thesis was to gain a more thorough understanding some of the 
hemodynamic and endocrine factors that play a role in the remodeling of the vascular 
wall of coronaries in hypertension, and the network of the saphenous vein in varicosity.  
 Differences between the sexes in terms of vascular remodeling in the coronary 
resistance arteries of the rat following early stages of angiotensin II induced 
hypertension was studied in a chronic Angiotensin II infusion model via in vitro 
pressure-angiometry. Different adaptation mechanisms were observes in males and 
females. Although we observed inward eutrophic remodeling in females, an increase in 
wall stress and elastic modulus dominated in males.  
  The effects of ovariectomy and hormone replacement on the remodeling of 
intramural coronaries were studied in the same chronic angiotensin II model, and via in 
vitro pressure angiometry. In hypertension, intramural small coronaries show inward 
eutrophic remodeling after ovariectomy comparing with hypertensive controls. Estrogen 
therapy had an opposite effect on vessel diameter. Hormone therapy led to an increase 
in spontaneous tone, allowing for greater dilatative capacity. Estrogen may therefore be 
considered to counterbalance some of the adverse changes seen in the wall of intramural 
coronaries in the early stages of chronic hypertension. 
  The effects of an increase in venous pressure and decrease of venous flow on the 
saphenous vein in chronic main branch low-flow high pressure stricture model in rats 
was studied via a partial chronic occlusion model. In vitro pressure-angiometry, 
intravital videomicroscopy, hemodynamic measurements, histology and immune-
histology of the main branch and preparation of Batson 17 plastic casts were performed. 
Contrary to expectations, the main branch did not dilate morphologically, instead 
involution with morphologically reduced lumen, reduced wall thickness and reduced 
wall mass was observed. A rich collateral system appeared on the clipped side. 
Loosening of the force-bearing elements during flow-induced wall remodeling may be 







 Jelen tanulmány célja a hipertóniában, illetve a vena saphena hálózatában 
kialakuló varicositásbetegségben kialakuló érfalátépülés hemodinamikai illetve 
endokrin hátterének feltérképezése. 
 Krónikus angiotenzin II infúzió adagolása mellett vizsgáltuk a nemek közötti 
különbségeket az intramurális koronáriák érfalátépüléséban a következményesen 
kialakult korai hypertoniában; az érszakaszokat nyomás-angiometriai vizsgálatnak 
vetettük alá. A hímek illetve a nőstények különböző módon reagáltak a 
nyomásemelkedésre. A nőstények jelentősebb relaxációt mutattak bradykinin adása 
esetében. A nőstények eutróf érfalátépüléssel, míg a hímek magasabb falstressz 
értékekkel, illetve emelkedettebb elasztikus modulussal reagáltak a nyomásterhelésre.  
  Ugyanezt az angiotenzin II indukálta magasvérnyomás állatmodellt alkalmaztuk 
az ovariektómia és a hormonpótlás tanulmányozása céljából. Az érszakaszokat ebben az 
esetben is nyomás-angiometriával vizsgáltuk. Hipertóniában ovariektomiát követően az 
intramurális koronáriákon eutróf érátépülést tapasztaltunk a hipertenzív csoporthoz 
képest. Az ösztogénkezelés hatása ezzel ellentétes volt az érátmérő tekintetében. A 
hormonpótlás fokozta a vizsgált érszakaszok spontán tónusát, így egyben növelték a 
dilatációs tartalákot. Tekinthetjük tehát úgy, hogy az ösztrogén ellensúlyozhatja a korai 
hipertóniában tapasztalt érfalelváltozások egy részét az intramurális koronáriákban. 
  A vena sephena beömléséhez felhelyezett részleges okklúzió segítségével 
kialakított állatmodellen vizsgálatuk a nyomásterhelés és áramláscsökkenés hatását a 
vena saphena ágrendszerére. In vitro nyomás-angiometria mellett intravitális 
videomikroszkópos vizsgálatokat, hemodinamikai méréseket, szövettni és 
immunhisztológiai vizsgálatokat végeztünk, valamint Batson 17 mintákat készítettünk.  
A várakozásokkal ellentétben a vena saphena főága nem tágult ki, hanem involúciót 
tapasztaltunk, morfológiailag csökkent lumen, csökkent falvastagság illetve faltömeg 
mellett. Az klippelt oldalon gazdag kollaterálisrendszer kialakulását tapasztaltuk. A 
varikózitásbetegség kialakulásában a struktúrális elemek fellazulása fontos pathológiai 
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